Systems/NNS
Biological/JJ
Approaches/NNS
Reveal/JJ
Non-additive/JJ
Responses/NNS
and/CC
Multiple/JJ
Crosstalk/NN
Mechanisms/NNS
between/IN
TLR/NN
and/CC
GPCR/NN
Signaling/NN
./.
====================
A/DT
variety/NN
of/IN
ligands/NNS
differ/VBP
in/IN
their/PRP$
capacity/NN
to/TO
bind/VB
the/DT
receptor/NN
,/,
elicit/VBP
gene/NN
expression/NN
,/,
and/CC
modulate/VBP
physiological/JJ
responses/NNS
./.
====================
Such/JJ
receptors/NNS
include/VBP
Toll-like/JJ
receptors/NNS
(/(
TLRs/NNS
)/)
,/,
which/WDT
recognize/VBP
various/JJ
patterns/NNS
of/IN
pathogens/NNS
and/CC
lead/VBP
to/TO
primary/JJ
innate/JJ
immune/JJ
activation/NN
against/IN
invaders/VBZ
,/,
and/CC
G-protein/NN
coupled/VBN
receptors/NNS
(/(
GPCRs/NNS
)/)
,/,
whose/WP$
interaction/NN
with/IN
their/PRP$
cognate/JJ
ligands/NNS
activates/VBZ
heterotrimeric/JJ
G/NN
proteins/NNS
and/CC
regulates/VBZ
specific/JJ
downstream/JJ
effectors/NNS
,/,
including/VBG
immuno-stimulating/VBG
molecules/NNS
./.
====================
Once/RB
TLRs/NNS
are/VBP
activated/VBN
,/,
they/PRP
lead/VBP
to/TO
the/DT
expression/NN
of/IN
hundreds/VBZ
of/IN
genes/NNS
together/RB
and/CC
bridge/NN
the/DT
arm/NN
of/IN
innate/JJ
and/CC
adaptive/JJ
immune/JJ
responses/NNS
./.
====================
We/PRP
characterized/VBD
the/DT
gene/NN
expression/NN
profile/NN
of/IN
Toll-like/JJ
receptor/NN
4/CD
(/(
TLR4/NN
)/)
in/IN
RAW/NN
264.7/CD
cells/NNS
when/WRB
it/PRP
bound/VBD
with/IN
its/PRP$
ligand/NN
,/,
2-keto-3-deoxyoctonate/JJ
(/(
KDO/NN
)/)
,/,
the/DT
active/JJ
part/NN
of/IN
lipopolysaccharide/NN
./.
====================
In/IN
addition/NN
,/,
to/TO
determine/VB
the/DT
network/NN
communications/NNS
among/IN
the/DT
TLR/NN
,/,
Janus/NN
kinase/NN
(/(
JAK/NN
)/)
/signal/JJ
transducer/NN
and/CC
activator/NN
of/IN
transcription/NN
(/(
STAT/NN
)/)
,/,
and/CC
GPCR/NN
,/,
we/PRP
tested/VBD
RAW/NN
264.7/CD
cells/NNS
with/IN
KDO/NN
,/,
interferon-β/JJ
,/,
or/CC
cAMP/NN
analog/NN
8-Br/NN
./.
====================
The/DT
ligands/NNS
were/VBD
also/RB
administered/VBN
as/IN
a/DT
pair/NN
of/IN
double/JJ
and/CC
triple/JJ
combinations/NNS
./.
====================
Cells/NNS
perceive/JJ
changes/NNS
in/IN
the/DT
extracellular/JJ
environment/NN
and/CC
create/VBP
appropriate/JJ
responses/NNS
through/IN
a/DT
complex/NN
network/NN
of/IN
interwoven/JJ
signaling/NN
cascades/NNS
./.
====================
For/IN
example/NN
,/,
lipopolysaccharide/NN
(/(
LPS/NN
)/)
causes/VBZ
severe/JJ
inflammatory/JJ
responses/NNS
by/IN
binding/VBG
to/TO
and/CC
signaling/NN
through/IN
Toll-like/JJ
receptor/NN
4/CD
(/(
TLR4/NN
)/)
on/IN
the/DT
cell/NN
surface/NN
,/,
and/CC
events/NNS
downstream/RB
of/IN
TLR/NN
stimulation/NN
are/VBP
extremely/RB
dynamic/JJ
[/(
1/CD
,/,
2/CD
]/)
./.
====================
The/DT
inner/JJ
core/NN
regions/NNS
of/IN
all/DT
LPS/NN
molecules/NNS
contain/VBP
at/IN
least/JJS
one/CD
2-keto-3-deoxyoctonic/JJ
acid/NN
(/(
KDO/NN
)/)
residue/NN
,/,
which/WDT
possesses/VBZ
endotoxin/NN
toxicity/NN
that/IN
is/VBZ
nearly/RB
equivalent/JJ
to/TO
LPS/NN
itself/PRP
[/(
3/CD
,/,
4/CD
]/)
./.
====================
We/PRP
studied/VBD
how/WRB
KDO-mediated/JJ
signal/NN
transduction/NN
through/IN
TLR4/NN
could/MD
be/VB
modulated/VBN
by/IN
the/DT
presence/NN
of/IN
interferon-β/JJ
(/(
IFN-β/JJ
)/)
and/or/CC
8-bromoadenosine-3',5'-cyclic/JJ
monophosphate/NN
(/(
8-Br/CD
)/)
./.
====================
IFN-β/JJ
uses/VBZ
the/DT
Janus/NN
kinase/NN
(/(
JAK/NN
)/)
/signal/JJ
transducer/NN
and/CC
activator/NN
of/IN
transcription/NN
(/(
STAT/NN
)/)
pathway/NN
,/,
and/CC
8-Br/JJ
is/VBZ
a/DT
cell-permeable/JJ
analog/NN
of/IN
cAMP/NN
that/IN
is/VBZ
regulated/VBN
by/IN
Gαs-/JJ
or/CC
Gαi-coupled/JJ
G/NN
protein-coupled/JJ
receptor/NN
(/(
GPCR/NN
)/)
./.
====================
In/IN
response/NN
to/TO
LPS/NN
,/,
TLR4/NN
activates/VBZ
the/DT
MyD88-independent/JJ
pathway/NN
to/TO
produce/VB
tumor/NN
necrosis/NN
factor/NN
α/RB
(/(
TNFα/NN
)/)
[/(
5/CD
]/)
,/,
whereas/IN
8-Br/JJ
activates/VBZ
cyclic/JJ
AMP/NN
response/NN
element-binding/JJ
protein/NN
(/(
CREB/NN
)/)
,/,
which/WDT
binds/VBZ
to/TO
cAMP-responsive/JJ
element/NN
(/(
CRE/NN
)/)
sequences/NNS
,/,
5'-TGACGTCA-3/NN
'/``
,/,
and/CC
is/VBZ
also/RB
a/DT
substrate/JJ
for/IN
various/JJ
cellular/JJ
kinases/NNS
[/(
6-10/CD
]/)
./.
====================
The/DT
rationale/JJ
behind/VBP
the/DT
present/JJ
investigation/NN
was/VBD
to/TO
understand/VB
the/DT
pathway/NN
interactions/NNS
among/IN
KDO/NN
,/,
IFN-β/JJ
,/,
and/CC
8-Br/NN
and/CC
how/WRB
each/DT
of/IN
these/DT
pathways/NNS
modulates/VBZ
the/DT
signaling/NN
from/IN
others/NNS
./.
====================
If/IN
two/CD
separate/JJ
pathways/NNS
triggered/VBN
by/IN
two/CD
distinct/JJ
ligands/NNS
regulate/VBP
the/DT
transcription/NN
of/IN
the/DT
same/JJ
gene/NN
,/,
then/RB
concomitant/JJ
stimulation/NN
with/IN
both/DT
of/IN
the/DT
ligands/NNS
should/MD
result/VB
in/IN
an/DT
additive/JJ
response/NN
equivalent/JJ
to/TO
the/DT
sum/NN
of/IN
the/DT
separate/JJ
responses/NNS
[/(
11/CD
]/)
./.
====================
In/IN
contrast/NN
,/,
if/IN
the/DT
pathways/NNS
intersect/JJ
or/CC
modulate/VBP
each/DT
other/JJ
,/,
concomitant/JJ
addition/NN
of/IN
the/DT
ligands/NNS
would/MD
yield/VB
a/DT
non-additive/JJ
response/NN
that/DT
is/VBZ
either/CC
greater/JJR
than/IN
or/CC
less/RBR
than/IN
the/DT
expected/VBN
additive/JJ
response/NN
./.
====================
Cells/NNS
,/,
reagents/NNS
,/,
and/CC
RNA/NN
preparation/NN
====================
RAW/NN
264.7/CD
macrophages/NNS
were/VBD
stimulated/VBN
with/IN
KDO/NN
(/(
100/CD
ng/mL/NN
)/)
,/,
IFN-β/JJ
(/(
300/CD
pM/NN
)/)
,/,
and/or/CC
8-Br/NN
(/(
100/CD
µM/NN
)/)
./.
====================
These/DT
ligands/NNS
were/VBD
applied/VBN
individually/RB
or/CC
in/IN
combinations/NNS
containing/VBG
KDO/NN
for/IN
60/CD
min/NN
and/CC
120/CD
min/NN
./.
====================
Total/JJ
RNA/NN
was/VBD
extracted/VBN
using/VBG
TriPure/JJ
(/(
Roche/NNP
,/,
Indianapolis/FW
,/,
IN/NN
,/,
USA/NN
)/)
following/VBG
the/DT
manufacturer/NN
's/POS
protocol/NN
./.
====================
Each/DT
experiment/NN
was/VBD
conducted/VBN
in/IN
duplicate/JJ
./.
====================
Oligonucleotide/NN
array/NN
fabrication/NN
and/CC
annotation/NN
====================
Mouse/NN
oligonucleotide/NN
arrays/NNS
were/VBD
fabricated/VBN
with/IN
15,631/CD
oligomers/NNS
that/WDT
were/VBD
65/CD
bp/NN
or/CC
70/CD
bp/NN
long/JJ
./.
====================
The/DT
oligomers/NNS
were/VBD
purchased/VBN
from/IN
Operon/NN
(/(
Huntsville/NNP
,/,
AL/NN
,/,
USA/NNP
)/)
and/CC
Sigma-Genosys/NNS
(/(
St./NNP
Louis/JJ
,/,
MO/NN
,/,
USA/NNP
)/)
and/CC
were/VBD
inkjet-printed/VBN
onto/IN
glass/NN
slides/NNS
by/IN
Agilent/JJ
Technologies/NNS
(/(
Santa/NN
Clara/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
./.
====================
The/DT
list/NN
of/IN
genes/NNS
is/VBZ
available/JJ
through/IN
the/DT
Gene/NN
Expression/NN
Omnibus/NN
(/(
GEO/NN
,/,
http/NN
:/:
//www.ncbi.nlm.nih.gov/geo/JJ
)/)
under/IN
accession/NN
number/NN
GPL254/NN
./.
====================
Gene/NN
expression/NN
analysis/NN
====================
Hybridization/NN
and/CC
the/DT
resulting/VBG
analyses/NNS
were/VBD
performed/VBN
as/IN
previously/RB
described/VBN
[/(
11-13/CD
]/)
./.
====================
Cy5-labeled/JJ
cRNA/NN
(/(
from/IN
ligand-treated/JJ
cells/NNS
)/)
and/CC
Cy3-labeled/JJ
cRNA/NN
(/(
from/IN
time-matched/JJ
controls/NNS
)/)
were/VBD
hybridized/VBN
in/IN
the/DT
array/NN
./.
====================
Dye-swap/NN
labeling/NN
was/VBD
performed/VBN
for/IN
each/DT
pair/NN
of/IN
samples/NNS
./.
====================
The/DT
arrays/NNS
were/VBD
scanned/VBN
with/IN
an/DT
Agilent/JJ
Scanner/NN
G2505A/NN
(/(
Agilent/JJ
Technologies/NNS
)/)
,/,
and/CC
image/NN
files/NNS
were/VBD
extracted/VBN
with/IN
background/NN
subtraction/NN
and/CC
dye/NN
normalization/NN
using/VBG
Agilent/JJ
G2566AA/NN
Extraction/NN
Software/JJ
version/NN
A.6.1.1/NN
(/(
Agilent/JJ
Technologies/NNS
)/)
./.
====================
The/DT
microarray/NN
data/NNS
used/VBN
in/IN
this/DT
study/NN
were/VBD
deposited/VBN
into/IN
GEO/NN
(/(
http/NN
:/:
//www.ncbi.nlm.nih.gov/geo/JJ
)/)
under/IN
the/DT
series/NN
accession/NN
number/NN
GSE11449/NN
and/CC
platform/NN
ID/NN
GPL254/NN
./.
====================
Quantitative/JJ
real-time/NN
PCR/NN
(/(
QRT-PCR/NN
)/)
====================
Selected/VBN
genes/NNS
were/VBD
subjected/VBN
to/TO
real-time/VB
PCR/NN
analysis/NN
in/IN
duplicate/JJ
using/VBG
the/DT
7500/CD
Real-Time/NN
PCR/NN
System/NN
(/(
Applied/VBN
Biosystems/NNS
,/,
Foster/NN
City/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
following/VBG
the/DT
protocol/NN
provided/VBD
by/IN
the/DT
manufacturer/NN
./.
====================
The/DT
measurement/NN
was/VBD
normalized/VBN
to/TO
a/DT
β/JJ
actin/NN
RNA/NN
control/NN
./.
====================
The/DT
primers/NNS
of/IN
genes/NNS
are/VBP
as/IN
follows/VBZ
:/:
TNF/NN
,/,
F/NN
5'-TCA/NN
GCG/NN
AGG/NN
ACA/NN
GCA/NN
AGG-3/NN
'/``
,/,
R/NN
5'-GTG/NN
AGT/NN
GAA/NN
AGG/NN
GAC/NN
AGA/NN
ACC-3/NN
'/``
;/:
β-actin/RB
,/,
F/NN
5'-CTT/NN
TGC/NN
AGC/NN
TCC/NN
TTC/NN
GTT/NN
GC-3/NN
'/``
,/,
R/NN
5'-ACG/NN
ATG/NN
GAG/NN
GGG/NNS
AAT/NN
ACAGC-3/NN
'/``
./.
====================
The/DT
remaining/VBG
primer/NN
sequences/NNS
are/VBP
available/JJ
upon/IN
request/VBP
./.
====================
Cytokine/NN
analysis/NN
====================
The/DT
Bio-Plex/NN
cytokine/NN
assay/NN
(/(
Bio-Rad/NNP
Laboratory/JJ
,/,
Hercules/NNS
,/,
CA/NNP
,/,
USA/NN
)/)
was/VBD
used/VBN
for/IN
quantification/NN
of/IN
cytokines/NNS
in/IN
tissue/NN
culture/NN
supernatants/NNS
./.
====================
In/IN
the/DT
kit/NN
,/,
an/DT
antibody/NN
directed/VBN
against/IN
each/DT
cytokine/NN
is/VBZ
covalently/RB
coupled/VBN
to/TO
a/DT
different/JJ
color-coded/JJ
polystyrene/NN
bead/RB
./.
====================
The/DT
conjugated/JJ
beads/VBZ
are/VBP
reacted/VBN
with/IN
a/DT
sample/JJ
containing/VBG
a/DT
known/JJ
(/(
standard/JJ
)/)
or/CC
unknown/JJ
amount/NN
of/IN
cytokines/NNS
./.
====================
After/IN
unbound/JJ
cytokines/NNS
are/VBP
removed/VBN
,/,
biotinylated/VBN
detection/NN
antibodies/NNS
are/VBP
added/VBN
to/TO
the/DT
reaction/NN
./.
====================
The/DT
complexes/NNS
are/VBP
detected/VBN
by/IN
streptavidin-phycoerythrin/NN
,/,
which/WDT
has/VBZ
fluorescence/NN
characteristics/NNS
./.
====================
Quantification/NN
is/VBZ
carried/VBN
out/RP
by/IN
a/DT
specialized/VBN
microtiter/NN
plate/NN
reader/NN
./.
====================
Protein/NN
phosphorylation/NN
====================
Sodium/NN
dodecyl/NN
sulfate-polyacrylamide/JJ
gel/NN
electrophoresis/NN
was/VBD
performed/VBN
to/TO
resolve/VB
a/DT
mixture/NN
of/IN
proteins/NNS
by/IN
size/NN
./.
====================
The/DT
resolved/JJ
proteins/NNS
were/VBD
transferred/VBN
from/IN
the/DT
gel/NN
to/TO
a/DT
nitrocellulose/JJ
membrane/NN
(/(
Invitrogen/NN
,/,
Carlsbad/NN
,/,
CA/NN
,/,
USA/NN
)/)
via/IN
electroelution/NN
./.
====================
The/DT
blot/NN
was/VBD
processed/VBN
for/IN
detection/NN
of/IN
specific/JJ
phosphoproteins/NNS
with/IN
a/DT
mixture/NN
of/IN
antibodies/NNS
./.
====================
All/DT
of/IN
the/DT
incubations/NNS
and/CC
washes/NNS
were/VBD
conducted/VBN
at/IN
room/JJ
temperature/NN
with/IN
gentle/JJ
shaking/VBG
using/VBG
an/DT
oscillating/JJ
platform/NN
shaker/NN
./.
====================
A/DT
Molecular/JJ
Dynamics/NNS
Storm/NN
860/CD
gel/NN
and/CC
a/DT
blot/NN
analysis/NN
system/NN
(/(
Amersham/NN
Pharmacia/NN
Biotech/NNP
,/,
Piscataway/NN
,/,
NJ/NN
,/,
USA/NN
)/)
were/VBD
used/VBN
./.
====================
Data/NNS
selection/NN
,/,
analysis/NN
,/,
and/CC
visualization/NN
====================
Features/NNS
that/DT
were/VBD
differentially/RB
expressed/VBN
in/IN
response/NN
to/TO
ligand/NN
stimulation/NN
were/VBD
identified/VBN
with/IN
Linear/JJ
Models/NNS
for/IN
Microarray/NN
Data/NNS
(/(
LIMMA/NN
,/,
http/NN
:/:
//bioinf.wehi.edu.au/limma/NN
)/)
./.
====================
The/DT
Benjamini-Hochberg/NN
method/NN
was/VBD
used/VBN
to/TO
control/VB
the/DT
false/NN
discovery/NN
rate/NN
[/(
14/CD
]/)
./.
====================
Four/CD
independent/JJ
experiments/NNS
were/VBD
used/VBN
to/TO
identify/VB
differentially/RB
expressed/VBN
genes/NNS
,/,
and/CC
p/NN
</JJR
0.05/CD
by/IN
ANOVA/NN
was/VBD
deemed/VBN
statistically/RB
significant/JJ
./.
====================
The/DT
average/JJ
log2-/NN
(/(
treated/control/NN
)/)
and/CC
the/DT
average/NN
difference/NN
(/(
avg.DIF/NN
)/)
were/VBD
hierarchically/RB
clustered/VBN
to/TO
visualize/VB
the/DT
patterns/NNS
of/IN
gene/NN
expression/NN
changes/NNS
and/CC
the/DT
nonadditivity/NN
,/,
respectively/RB
[/(
15/CD
]/)
./.
====================
Only/RB
features/NNS
with/IN
significant/JJ
expression/NN
changes/NNS
and/CC
significant/JJ
nonadditive/JJ
responses/NNS
at/IN
one/CD
or/CC
more/RBR
time/NN
points/NNS
were/VBD
included/VBN
,/,
respectively/RB
./.
====================
Clustering/NN
was/VBD
done/VBN
one/CD
way/NN
across/IN
the/DT
features/NNS
with/IN
experimental/JJ
conditions/NNS
aligned/VBD
in/IN
ligand/NN
,/,
followed/VBN
by/IN
time/NN
course/NN
orders/NNS
./.
====================
Euclidean/JJ
correlation/NN
coefficient/JJ
and/CC
complete/JJ
linkage/NN
were/VBD
used/VBN
as/IN
similarity/NN
metrics/NNS
[/(
16/CD
]/)
./.
====================
The/DT
hierarchical/JJ
clustering/NN
program/NN
that/DT
was/VBD
used/VBN
was/VBD
implemented/VBN
in/IN
the/DT
Multiple/JJ
Experiment/JJ
Viewer/JJR
(/(
MeV/NN
,/,
www.tigr.org/software/tm4/mev.html/NN
)/)
./.
====================
Ingenuity/NN
pathway/NN
analysis/NN
(/(
IPA/NN
)/)
====================
Gene/NN
accession/NN
numbers/NNS
,/,
fold-changes/VBZ
of/IN
each/DT
treatment/NN
,/,
and/CC
p-value/JJ
were/VBD
loaded/VBN
into/IN
the/DT
IPA5.0/NN
software/JJ
(/(
http/NN
:/:
//www.ingenuity.com/JJ
)/)
./.
====================
The/DT
genes/NNS
were/VBD
grouped/VBN
with/IN
their/PRP$
molecular/JJ
functions/NNS
and/CC
depicted/JJ
as/IN
a/DT
network/NN
picture/NN
,/,
with/IN
their/PRP$
direct/JJ
and/CC
indirect/JJ
relationships/NNS
represented/VBN
with/IN
the/DT
gene/NN
ontology/NN
by/IN
the/DT
canonical/JJ
pathway/NN
analysis/NN
./.
====================
All/DT
these/DT
annotations/NNS
used/VBN
Kyoto/JJ
Encyclopedia/NN
of/IN
Genes/NNS
and/CC
Genomes/NNS
(/(
KEGG/NN
)/)
pathway/NN
maps/VBZ
,/,
and/CC
the/DT
most/JJS
significant/JJ
genes/NNS
were/VBD
summarized/VBN
in/IN
the/DT
network/NN
and/CC
as/IN
a/DT
graph/JJ
./.
====================
General/JJ
patterns/NNS
of/IN
gene/NN
signature/NN
in/IN
single-ligand/JJ
studies/NNS
====================
We/PRP
first/RB
characterized/VBN
gene/NN
expression/NN
profiles/NNS
after/IN
treating/VBG
RAW/NN
264.7/CD
macrophages/NNS
with/IN
the/DT
individual/JJ
ligands/NNS
in/IN
a/DT
kinetic/JJ
study/NN
(/(
60/CD
and/CC
120/CD
min/NN
)/)
./.
====================
We/PRP
found/VBD
that/IN
each/DT
of/IN
the/DT
three/CD
ligands/NNS
,/,
when/WRB
applied/VBN
singly/RB
,/,
exhibited/VBD
maximum/JJ
transcriptional/JJ
activation/NN
after/IN
120/CD
min/NN
of/IN
stimulation/NN
(/(
as/IN
analyzed/VBN
by/IN
Limma/NN
)/)
(/(
Fig/NN
./.
====================
1A/NN
)/)
./.
====================
We/PRP
further/RB
explored/VBD
the/DT
expression/NN
data/NNS
using/VBG
k-means/medians/NNS
clustering/NN
(/(
KMC/NN
)/)
in/IN
MeV/NN
,/,
in/IN
which/WDT
we/PRP
divided/VBD
the/DT
gene/NN
expression/NN
profiles/NNS
into/IN
clusters/NNS
in/IN
order/NN
to/TO
identify/VB
groups/NNS
of/IN
genes/NNS
that/WDT
might/MD
participate/VB
in/IN
similar/JJ
pathways/NNS
./.
====================
The/DT
clusters/NNS
that/WDT
exhibited/VBD
changes/NNS
greater/JJR
than/IN
2-fold/JJ
are/VBP
shown/VBN
in/IN
Fig/NN
./.
====================
1B/NN
./.
====================
Upon/IN
single-ligand/JJ
treatment/NN
,/,
KDO/NN
and/CC
IFN-β/JJ
mediated/VBN
robust/JJ
transcriptional/JJ
upregulation/NN
,/,
whereas/IN
8-Br/NN
stimulation/NN
resulted/VBD
in/IN
both/DT
up-/RB
and/CC
downregulation/NN
of/IN
gene/NN
expression/NN
./.
====================
The/DT
top-most/JJ
functions/NNS
of/IN
the/DT
genes/NNS
by/IN
all/DT
ligand/NN
treatment/NN
and/CC
major/JJ
networks/NNS
are/VBP
given/VBN
in/IN
Fig/NN
./.
====================
2/CD
./.
====================
KDO/NN
regulated/VBN
activators/NNS
and/CC
repressors/NNS
of/IN
immune/JJ
signaling/NN
====================
After/IN
classifying/VBG
the/DT
genes/NNS
by/IN
KMC/NN
,/,
we/PRP
subcategorized/VBD
them/PRP
according/VBG
to/TO
their/PRP$
functions/NNS
./.
====================
KDO-regulated/JJ
genes/NNS
included/VBD
transcription/NN
factors/NNS
and/CC
genes/NNS
involved/VBN
in/IN
inflammation/NN
,/,
immune/JJ
responses/NNS
,/,
signal/NN
transduction/NN
,/,
cell/NN
cycle/NN
regulation/NN
,/,
cell/NN
proliferation/NN
,/,
differentiation/NN
,/,
metabolism/NN
,/,
transport/VBP
,/,
cell/NN
adhesion/NN
,/,
and/CC
apoptosis/NN
(/(
Supplementary/JJ
Table/JJ
1/CD
)/)
./.
====================
As/IN
expected/VBN
,/,
KDO-treated/JJ
cells/NNS
exhibited/VBD
a/DT
gene/NN
regulation/NN
pattern/NN
similar/JJ
to/TO
that/DT
in/IN
LPS-treated/JJ
cells/NNS
,/,
which/WDT
included/VBD
upregulation/NN
of/IN
Tnf/JJ
,/,
Il-1α/NNP
,/,
Il-1β/NNP
,/,
Cxcl4/NN
,/,
and/CC
c-Myc/NN
./.
====================
Furthermore/RB
,/,
we/PRP
also/RB
observed/VBN
that/IN
KDO/NN
regulated/VBN
several/JJ
immediate/JJ
early/JJ
response/NN
genes/NNS
,/,
such/JJ
as/IN
Egr1/NN
,/,
Egr3/NN
,/,
Gadd45α/NNP
,/,
Dusp1/NN
,/,
and/CC
Dusp2/NN
,/,
all/DT
of/IN
which/WDT
are/VBP
reportedly/RB
upregulated/VBN
by/IN
LPS/NN
[/(
11/CD
]/)
./.
====================
Our/PRP$
results/NNS
indicated/VBD
that/IN
KDO/NN
elicits/VBZ
transcriptional/JJ
responses/NNS
that/DT
are/VBP
similar/JJ
in/IN
gene/NN
identity/NN
and/CC
potency/NN
to/TO
LPS/NN
responses/NNS
./.
====================
During/IN
the/DT
KDO-mediated/JJ
transcriptional/JJ
response/NN
in/IN
RAW/NN
264.7/CD
cells/NNS
,/,
many/JJ
of/IN
the/DT
genes/NNS
induced/VBN
at/IN
120/CD
min/NN
were/VBD
candidate/NN
feedback/NN
repressors/NNS
of/IN
signal/NN
transduction/NN
[/(
17/CD
]/)
./.
====================
Such/JJ
repressors/NNS
were/VBD
specific/JJ
to/TO
nuclear/JJ
factor-κB/NN
(/(
NF-κB/NN
)/)
and/CC
Il-1/NN
and/CC
include/VBP
nuclear/JJ
factor/NN
of/IN
kappa/NN
light/JJ
polypeptide/NN
gene/NN
enhancer/NN
in/IN
B-cells/NNS
inhibitor/NN
epsilon/NN
(/(
Nfκbie/NNP
,/,
also/RB
known/VBN
as/IN
IκBε/JJ
)/)
,/,
nuclear/JJ
factor/NN
of/IN
kappa/NN
light/JJ
polypeptide/NN
gene/NN
enhancer/NN
in/IN
B-cells/NNS
inhibitor/NN
zeta/NN
(/(
Nfκbiζ/NNP
,/,
also/RB
known/VBN
as/IN
Iκbζ/JJ
)/)
,/,
and/CC
interleukin/NN
1/CD
receptor/NN
antagonist/NN
(/(
Il-1ra/NN
)/)
./.
====================
In/IN
addition/NN
,/,
KDO/NN
upregulated/VBN
Tnfsf9/NN
,/,
Tnfaip3/NN
,/,
Traf1/NN
,/,
and/CC
Fas6/NN
,/,
indicating/VBG
that/IN
KDO/NN
has/VBZ
the/DT
potential/JJ
to/TO
elicit/VB
inflammation/NN
./.
====================
Its/PRP$
upregulation/NN
of/IN
Irf1/NN
suggested/VBD
that/IN
KDO/NN
also/RB
activated/VBD
interferon-stimulated/JJ
response/NN
elements/NNS
through/IN
the/DT
MyD88-independent/JJ
pathway/NN
./.
====================
Other/JJ
KDO-induced/JJ
genes/NNS
included/VBD
IFN-β/JJ
,/,
CD40/NN
,/,
Socs5/NN
,/,
Cish/JJ
,/,
Fosl1/NN
,/,
Rgs16/NN
,/,
CCR9/NN
,/,
Ifit3/NN
,/,
and/CC
cardiotropin/NN
1/CD
(/(
Ctf1/NN
)/)
./.
====================
Among/IN
these/DT
genes/NNS
,/,
Socs5/NN
and/CC
Cish/JJ
are/VBP
feedback/NN
inhibitors/NNS
of/IN
the/DT
JAK/STAT/NN
pathway/NN
;/:
both/CC
were/VBD
upregulated/VBN
after/IN
120/CD
min/NN
of/IN
stimulation/NN
./.
====================
KDO/DT
also/RB
promoted/VBD
Il-10/NN
expression/NN
after/IN
120/CD
min/NN
of/IN
stimulation/NN
;/:
this/DT
gene/NN
contains/VBZ
2/CD
Creb/NN
binding/VBG
sites/NNS
in/IN
its/PRP$
promoter/NN
;/:
so/RB
,/,
KDO/NN
may/MD
have/VB
upregulated/VBN
this/DT
gene/NN
through/IN
enhanced/VBN
phosphoinositide/NN
3-kinase/NN
(/(
PI3K/NN
)/)
-v-akt/RB
murine/JJ
thymoma/NN
viral/JJ
oncogene/NN
(/(
AKT/NN
)/)
-glycogen/NN
syntase/NN
kinase/NN
(/(
GSK/NN
)/)
pathway/NN
signaling/VBG
and/CC
Creb/NN
phosphorylation/NN
./.
====================
IFN-β/JJ
induced/VBD
gene/NN
expression/NN
of/IN
inflammatory/immune/JJ
responses/NNS
====================
Binding/NN
of/IN
IFN-β/JJ
to/TO
the/DT
Type/NN
I-IFN/CD
receptor/NN
activates/VBZ
the/DT
JAK/STAT/NN
signaling/NN
pathway/NN
./.
====================
Phosphorylated/VBN
Stat/NN
proteins/NNS
regulate/VBP
gene/NN
transcription/NN
by/IN
binding/VBG
to/TO
conserved/VBN
sequences/NNS
within/IN
the/DT
promoters/NNS
of/IN
IFN-induced/JJ
genes/NNS
./.
====================
IFN-stimulated/JJ
Stat/NN
activation/NN
mediates/VBZ
the/DT
expression/NN
of/IN
a/DT
second/JJ
family/NN
of/IN
transcription/NN
factors/NNS
,/,
the/DT
Irf/NN
proteins/NNS
[/(
18/CD
]/)
./.
====================
Irf/IN
proteins/NNS
also/RB
mediate/VBP
transcriptional/JJ
responses/NNS
to/TO
IFN/NN
stimulation/NN
./.
====================
In/IN
our/PRP$
study/NN
,/,
IFN-β/JJ
stimulation/NN
was/VBD
associated/VBN
with/IN
Stat2/NN
and/CC
Irf1/NN
production/NN
,/,
and/CC
recent/JJ
findings/NNS
indicate/VBP
that/IN
Irf/NNP
proteins/NNS
play/VBP
critical/JJ
roles/NNS
in/IN
interferon/NN
regulation/NN
[/(
19/CD
]/)
./.
====================
IFN-β/JJ
induced/VBD
a/DT
number/NN
of/IN
genes/NNS
involved/VBN
in/IN
inflammatory/immune/JJ
responses/NNS
,/,
transcription/NN
,/,
signaling/NN
,/,
and/CC
apoptosis/NN
./.
====================
The/DT
most/JJS
highly/RB
responsive/JJ
genes/NNS
induced/VBN
by/IN
IFN-β/JJ
were/VBD
interferon-inducible/JJ
GTPase/NN
1/CD
(/(
Iigp1/NN
)/)
,/,
Ifit1/NN
,/,
myxovirus/NN
(/(
influenza/NN
virus/NN
)/)
resistance/NN
2/CD
(/(
Mx2/NNP
)/)
,/,
Ifit2/NN
,/,
Cxcl9/NN
,/,
Cxcl10/NN
,/,
Cxcl11/NN
,/,
ISG15/NN
ubiquitin-like/JJ
modifier/NN
(/(
ISG15/NN
)/)
,/,
Socs1/NN
,/,
CD40/NN
,/,
and/CC
TLR3/NN
./.
====================
Secondary/JJ
responsive/JJ
genes/NNS
included/VBD
Gbp1/NN
,/,
Gbp2/NN
,/,
Gbp5/NN
,/,
Il-13/NN
,/,
and/CC
Fas/NN
./.
====================
The/DT
fold-changes/NNS
in/IN
the/DT
expression/NN
of/IN
these/DT
genes/NNS
are/VBP
provided/VBN
in/IN
Supplementary/JJ
Table/JJ
2/CD
./.
====================
8-Br/CD
differentially/RB
regulated/VBN
key/JJ
inflammatory/JJ
genes/NNS
====================
The/DT
8-Br-regulated/JJ
genes/NNS
were/VBD
involved/VBN
in/IN
transcription/NN
,/,
signaling/NN
,/,
inflammation/NN
,/,
apoptosis/NN
,/,
metabolism/NN
,/,
proteolysis/NN
,/,
transport/VBP
,/,
and/CC
cell/NN
cycle/NN
regulation/NN
(/(
Supplementary/JJ
Table/JJ
3/CD
)/)
./.
====================
Treating/VBG
cells/NNS
with/IN
8-Br/JJ
upregulated/VBN
several/JJ
immediate/JJ
early/JJ
transcriptional/JJ
targets/NNS
,/,
including/VBG
nuclear/JJ
receptor/NN
subfamily/RB
4/CD
group/NN
A/DT
member/NN
2/CD
(/(
Nr4a2/NN
)/)
,/,
Gadd45/NNP
beta/NN
,/,
Dusp1/NN
,/,
Pde4b/NN
,/,
Crem/NNP
,/,
Cebpb/NNP
,/,
Vegf/NNP
,/,
Bag3/NN
,/,
and/CC
v-maf/NN
musculoaponeurotic/JJ
fibrosarcoma/NN
oncogene/NN
family/NN
protein/NN
F/NN
(/(
Maff/NNP
)/)
./.
====================
Surprisingly/RB
,/,
we/PRP
observed/VBD
that/IN
8-Br/JJ
treatment/NN
downregulated/VBD
transcription/NN
of/IN
Rgs16/NN
,/,
Tnf/NNP
,/,
Cxcl4/NN
,/,
Ptger4/NN
,/,
Tnfsf9/NN
,/,
c-Myc/NN
,/,
and/CC
Map3k8/NN
by/IN
more/RBR
than/IN
2-fold/JJ
(/(
Fig/NN
./.
====================
3A/NN
)/)
./.
====================
8-Br/DT
can/MD
influence/VB
the/DT
mitogen-activated/JJ
protein/NN
kianse/NN
(/(
MAPK/NN
)/)
pathway/NN
by/IN
downregulating/VBG
Mapk3k8/NN
./.
====================
Map3k8/NN
activates/VBZ
the/DT
kinases/NNS
p38/NN
and/CC
JNK/NN
and/CC
the/DT
transcription/NN
factors/NNS
NF-κB/NN
and/CC
NF-AT/NN
,/,
although/IN
its/PRP$
specialized/VBN
role/NN
is/VBZ
to/TO
activate/VB
the/DT
extracellular/JJ
signal-regulated/JJ
protein/NN
kinase/NN
(/(
ERK/NN
)/)
pathway/NN
downstream/JJ
of/IN
most/JJS
TLR/NN
signals/NNS
[/(
20-23/CD
]/)
./.
====================
We/PRP
observed/VBD
8-Br-mediated/JJ
downregulation/NN
of/IN
2/CD
proto-oncogenes/NNS
,/,
c-Myc/NN
and/CC
Map3k8/NN
,/,
and/CC
a/DT
cell/NN
cycle/NN
gene/NN
,/,
Gadd45α/NNP
(/(
Supplementary/JJ
Table/JJ
3/CD
)/)
,/,
which/WDT
emphasizes/VBZ
that/DT
8-Br/JJ
cAMP/NN
may/MD
also/RB
have/VBP
important/JJ
inhibitory/JJ
roles/NNS
in/IN
cancer/NN
cell/NN
proliferation/NN
[/(
24/CD
,/,
25/CD
]/)
./.
====================
We/PRP
next/RB
hypothesized/VBN
that/IN
the/DT
co-downregulated/JJ
genes/NNS
may/MD
have/VB
common/JJ
transcription/NN
factor/NN
binding/VBG
sites/NNS
;/:
therefore/RB
,/,
we/PRP
examined/VBD
their/PRP$
promoter/NN
regions/NNS
using/VBG
TOUCAN/JJ
(/(
http/NN
:/:
//homes.esat.kuleuven.be/~saerts/software/toucan.php/JJ
)/)
and/CC
analyzed/VBD
the/DT
genes/NNS
downregulated/VBD
by/IN
8-Br/JJ
using/VBG
MotifMogul/JJ
(/(
http/NN
:/:
//xerad.systemsbiology.net/MotifMogulServer/RB
)/)
./.
====================
We/PRP
found/VBD
AP1/NN
and/or/CC
NF-κB/NN
subunit/NN
binding/NN
sites/NNS
in/IN
the/DT
upstream/JJ
regions/NNS
of/IN
all/DT
of/IN
the/DT
downregulated/JJ
genes/NNS
,/,
which/WDT
adds/VBZ
to/TO
evidence/NN
from/IN
previous/JJ
studies/NNS
[/(
26/CD
,/,
27/CD
]/)
./.
====================
Among/IN
these/DT
genes/NNS
were/VBD
several/JJ
classical/JJ
targets/NNS
of/IN
NF-κB/NN
(/(
for/IN
example/NN
,/,
Tnf/NNP
)/)
and/CC
AP-1/NN
(/(
for/IN
example/NN
,/,
c-Myc/NN
and/CC
Gadd45α/FW
)/)
;/:
these/DT
genes/NNS
are/VBP
highlighted/VBN
with/IN
arrows/NNS
in/IN
Fig/NN
./.
====================
3A/NN
and/CC
shown/VBN
in/IN
greater/JJR
detail/NN
in/IN
Fig/NN
./.
====================
3B/NN
./.
====================
Since/IN
protein/NN
kinase/NN
A/NN
(/(
PKA/NN
)/)
activation/NN
by/IN
cAMP/NN
suppresses/VBZ
the/DT
MAPK/NN
cascade/NN
through/IN
phosphorylation/NN
of/IN
Raf/NN
[/(
28/CD
]/)
,/,
we/PRP
can/MD
not/RB
exclude/VB
the/DT
possibility/NN
that/IN
elevated/JJ
cAMP/NN
may/MD
,/,
in/IN
part/NN
,/,
reduce/VBP
the/DT
transcription/NN
of/IN
the/DT
targeted/VBN
genes/NNS
by/IN
modulating/VBG
protein/NN
binding/VBG
to/TO
AP-1/NN
sites/NNS
,/,
by/IN
inhibiting/VBG
the/DT
ERK/NN
pathway/NN
through/IN
Raf/NN
,/,
and/or/CC
by/IN
specifically/RB
affecting/VBG
NF-κB/NN
subunits/NNS
./.
====================
Importantly/RB
,/,
Il-1β/NN
was/VBD
up-regulated/VBN
quickly/RB
,/,
whereas/IN
Il-1α/NN
and/CC
Il-10/NN
were/VBD
not/RB
affected/VBN
prior/JJ
to/TO
120/CD
min/NN
of/IN
stimulation/NN
./.
====================
This/DT
differential/JJ
mRNA/NN
regulation/NN
of/IN
genes/NNS
that/WDT
are/VBP
all/DT
involved/VBN
in/IN
inflammation/NN
suggested/VBD
that/IN
cAMP/NN
utilized/VBD
more/RBR
than/IN
one/CD
distinct/JJ
mechanism/NN
to/TO
alter/VB
the/DT
expression/NN
of/IN
specific/JJ
sets/NNS
of/IN
genes/NNS
./.
====================
Double-ligand/CC
studies/NNS
:/:
non-additive/JJ
responses/NNS
====================
To/TO
understand/VB
how/WRB
the/DT
presence/NN
of/IN
one/CD
or/CC
more/RBR
ligands/NNS
modified/VBN
the/DT
transcriptional/JJ
responses/NNS
to/TO
the/DT
other/JJ
ligands/NNS
,/,
we/PRP
evaluated/VBD
features/NNS
that/IN
exhibited/VBD
non-additive/JJ
responses/NNS
during/IN
the/DT
double-ligand/JJ
studies/NNS
and/CC
grouped/VBD
them/PRP
into/IN
three/CD
categories/NNS
:/:
significant/JJ
responses/NNS
1/CD
)/)
to/TO
both/DT
ligands/NNS
;/:
2/CD
)/)
to/TO
either/CC
ligand/NN
A/DT
or/CC
ligand/NN
B/NN
;/:
3/LS
)/)
to/TO
neither/CC
ligand/NN
(/(
Table/JJ
1/CD
)/)
./.
====================
A/DT
total/JJ
of/IN
433/CD
features/NNS
showed/VBD
non-additive/JJ
responses/NNS
above/IN
threshold/NN
levels/NNS
in/IN
at/IN
least/JJS
one/CD
of/IN
the/DT
double-ligand/JJ
studies/NNS
./.
====================
In/IN
all/DT
of/IN
the/DT
double-ligand/JJ
studies/NNS
involving/VBG
KDO/NN
,/,
we/PRP
found/VBD
differences/NNS
in/IN
gene/NN
transcription/NN
that/DT
were/VBD
not/RB
present/JJ
when/WRB
the/DT
ligands/NNS
were/VBD
applied/VBN
individually/RB
./.
====================
Applying/VBG
KDO/NN
together/RB
with/IN
IFN-β/JJ
augmented/VBD
IFN-β-mediated/JJ
transcriptional/JJ
responses/NNS
./.
====================
In/IN
contrast/NN
,/,
when/WRB
KDO/NN
was/VBD
combined/VBN
with/IN
8-Br/JJ
,/,
each/DT
ligand/NN
abrogated/VBD
the/DT
single-ligand/JJ
response/NN
of/IN
the/DT
other/JJ
./.
====================
KDO/NN
enhances/VBZ
IFN-β/JJ
signaling/NN
====================
KDO/NN
enhanced/VBD
IFN-β-dependent/JJ
signaling/NN
pathways/NNS
in/IN
a/DT
time-dependent/JJ
manner/NN
./.
====================
Since/IN
TLR4/NN
activation/NN
can/MD
also/RB
produce/VBP
IFN-β/JJ
,/,
the/DT
KDO-mediated/JJ
enhancement/NN
suggested/VBD
cooperation/NN
between/IN
exogenously/RB
applied/VBN
and/CC
endogenously/RB
produced/VBN
IFN-β/JJ
(/(
Supplementary/JJ
Table/JJ
4/CD
)/)
./.
====================
Several/JJ
IFN-β/JJ
and/CC
KDO/NN
primary/JJ
responsive/JJ
genes/NNS
were/VBD
upregulated/VBN
,/,
including/VBG
genes/NNS
that/WDT
activate/VBP
the/DT
immune/JJ
system/NN
./.
====================
In/IN
some/DT
cases/NNS
,/,
the/DT
IFN-β/JJ
gene/NN
signature/NN
dominated/JJ
over/IN
the/DT
KDO/NN
gene/NN
signature/NN
./.
====================
For/IN
example/NN
,/,
IFN-β/JJ
inhibited/VBD
two/CD
KDO/NN
primary/JJ
responsive/JJ
genes/NNS
,/,
Il-1ra/NN
and/CC
Nfκbζ/JJ
,/,
but/CC
KDO/NN
did/VBD
not/RB
change/VB
the/DT
expression/NN
of/IN
any/DT
of/IN
the/DT
interferon-responsive/JJ
primary/JJ
genes/NNS
./.
====================
The/DT
expression/NN
levels/NNS
of/IN
select/JJ
genes/NNS
were/VBD
validated/VBN
by/IN
using/VBG
QRT-PCR/NN
(/(
Fig/NN
./.
====================
4/CD
)/)
./.
====================
Cytokine/NN
assays/NNS
,/,
conducted/VBN
following/VBG
a/DT
combination/NN
of/IN
LPS/NN
and/CC
IFN-β/JJ
treatment/NN
,/,
also/RB
demonstrated/VBD
non-additive/JJ
enhancement/NN
of/IN
Il-6/NN
,/,
Il-10/NN
,/,
RANTES/NN
,/,
and/CC
TNF/NN
protein/NN
levels/NNS
(/(
Fig/NN
./.
====================
5A/CD
)/)
./.
====================
This/DT
increase/NN
could/MD
be/VB
due/JJ
to/TO
synergistic/JJ
production/NN
of/IN
transcription/NN
factors/NNS
in/IN
response/NN
to/TO
these/DT
ligands/NNS
,/,
apart/VBP
from/IN
their/PRP$
classical/JJ
transcription/NN
factors/NNS
./.
====================
It/PRP
is/VBZ
likely/JJ
that/IN
the/DT
rapid/JJ
,/,
greater-than-2-fold/RB
increase/VBP
in/IN
Socs1/NN
and/CC
Cish/JJ
production/NN
may/MD
have/VB
contributed/VBN
to/TO
the/DT
attenuated/VBN
expression/NN
of/IN
the/DT
KDO/NN
secondary/JJ
responsive/JJ
genes/NNS
[/(
29/CD
,/,
30/CD
]/)
./.
====================
Il-10/NN
is/VBZ
an/DT
anti-inflammatory/JJ
cytokine/NN
regulated/VBN
through/IN
the/DT
PI3K-AKT-GSK-CREB/NN
pathway/NN
[/(
31/CD
,/,
32/CD
]/)
,/,
and/CC
we/PRP
noted/VBD
its/PRP$
expression/NN
after/IN
120/CD
min/NN
of/IN
stimulation/NN
,/,
suggesting/VBG
that/IN
the/DT
PI3K/NN
pathway/NN
may/MD
have/VB
been/VBN
activated/VBN
after/IN
60/CD
min/NN
of/IN
stimulation/NN
./.
====================
KDO-/NN
and/CC
IFN-β-treated/JJ
cells/NNS
exhibited/VBD
upregulation/NN
of/IN
many/JJ
interferon-regulatory/JJ
factors/NNS
(/(
IRFs/NNS
)/)
,/,
including/VBG
Irf1/NN
,/,
Irf4/NNP
,/,
and/CC
Irf8/NN
./.
====================
Irf4/DT
inhibits/VBZ
the/DT
expression/NN
of/IN
MyD88-dependent/JJ
IRF/NN
genes/NNS
by/IN
competing/VBG
with/IN
IRF5/NN
for/IN
binding/VBG
to/TO
the/DT
same/JJ
region/NN
of/IN
MyD88/NN
[/(
33/CD
]/)
./.
====================
Combined/JJ
KDO/NN
and/CC
IFN/NN
treatment/NN
also/RB
upregulated/VBD
genes/NNS
with/IN
IRF3/NN
binding/NN
sites/NNS
in/IN
their/PRP$
promoters/NNS
;/:
i.e./FW
,/,
Ifit1/NN
,/,
Ifit2/NN
,/,
Ifit3/NN
,/,
Isg15/NN
,/,
and/CC
Gbp1/NN
./.
====================
Our/PRP$
gene/NN
profiling/VBG
results/NNS
suggested/VBD
that/IN
IRF3/NN
is/VBZ
sufficient/JJ
to/TO
induce/VB
antiviral/JJ
responses/NNS
at/IN
the/DT
initial/JJ
activation/NN
time/NN
point/NN
,/,
consistent/JJ
with/IN
an/DT
earlier/RBR
report/VBP
that/IN
demonstrated/VBD
a/DT
role/NN
for/IN
IRF3-dependent/JJ
genes/NNS
in/IN
establishing/VBG
antiviral/JJ
responses/NNS
in/IN
Jurkat/NN
cells/NNS
[/(
34/CD
]/)
./.
====================
KDO/NN
and/CC
IFN-β/JJ
regulate/VBP
gamma/NN
activated/VBN
sequence/NN
(/(
GAS/NN
)/)
genes/NNS
together/RB
====================
Interestingly/RB
,/,
two/CD
of/IN
the/DT
genes/NNS
that/WDT
exhibited/VBD
non-additive/JJ
responses/NNS
are/VBP
produced/VBN
only/RB
by/IN
IFN-γ/JJ
GAS/NN
elements/NNS
:/:
Irf8/NNP
,/,
previously/RB
known/VBN
as/IN
interferon/NN
consensus/NN
sequence-binding/NN
protein/NN
1/CD
(/(
ICSBP/NN
)/)
,/,
and/CC
transporter/JJ
associated/VBN
with/IN
antigen/NN
processing-1/NN
(/(
Tap1/NN
)/)
./.
====================
Upregulation/NN
of/IN
GAS-driven/JJ
genes/NNS
requires/VBZ
the/DT
Stat1/NN
homodimer/NN
exclusively/RB
but/CC
not/RB
NF-κB/NN
;/:
they/PRP
are/VBP
both/CC
produced/VBN
by/IN
IFN-γ/JJ
./.
====================
Interestingly/RB
,/,
in/IN
our/PRP$
study/NN
,/,
we/PRP
did/VBD
not/RB
observe/VB
elevated/JJ
expression/NN
of/IN
IFN-γ/JJ
or/CC
STAT1/NN
mRNA/NN
,/,
but/CC
we/PRP
still/RB
observed/VBN
the/DT
production/NN
of/IN
GAS-driven/JJ
genes/NNS
./.
====================
Two/CD
phosphorylation/NN
sites/NNS
,/,
Tyr-701/NN
and/CC
Ser-727/NN
,/,
differentially/RB
regulate/VBP
Stat1/NN
,/,
and/CC
phosphorylation/NN
of/IN
both/DT
sites/NNS
is/VBZ
required/VBN
for/IN
maximal/JJ
transcriptional/JJ
activity/NN
[/(
35/CD
,/,
36/CD
]/)
./.
====================
A/DT
previous/JJ
study/NN
demonstrated/VBD
that/IN
Stat1/NN
is/VBZ
phosphorylated/VBN
on/IN
both/CC
Tyr-701/NN
and/CC
Ser-727/NN
in/IN
LPS-treated/JJ
cells/NNS
after/IN
2/CD
h/NN
[/(
37/CD
]/)
./.
====================
We/PRP
surmise/VBP
that/DT
this/DT
enhanced/VBN
phosphorylation/NN
of/IN
STAT1/NN
may/MD
be/VB
mediated/VBN
by/IN
KDO/NN
and/CC
IFN-β/JJ
./.
====================
However/RB
,/,
when/WRB
we/PRP
conducted/VBD
STAT1/NN
phosphoprotein/NN
measurements/NNS
with/IN
KDO/NN
and/CC
IFN-β/JJ
in/IN
combination/NN
,/,
we/PRP
observed/VBD
a/DT
3-fold/JJ
upregulation/NN
in/IN
phosphorylated/VBN
STAT1/NN
after/IN
30/CD
min/NN
(/(
Fig/NN
./.
====================
5B/NN
)/)
./.
====================
This/DT
increase/NN
in/IN
phosphorylated/VBN
STAT1/NN
during/IN
double-ligand/JJ
stimulation/NN
was/VBD
lower/JJR
than/IN
the/DT
increase/NN
in/IN
phosphorylation/NN
of/IN
STAT1/NN
induced/VBD
by/IN
IFN-β/JJ
alone/RB
(/(
10-fold/JJ
)/)
./.
====================
Our/PRP$
previous/JJ
studies/NNS
with/IN
LPS-/NN
and/CC
IFN-γ-treated/JJ
RAW/NN
264.7/CD
cells/NNS
also/RB
showed/VBD
non-additive/JJ
increases/VBZ
in/IN
Irf8/NN
and/CC
Tap1/NN
gene/NN
expression/NN
[/(
11/CD
]/)
./.
====================
This/DT
elevated/JJ
GAS/NN
gene/NN
expression/NN
definitively/RB
indicated/VBD
that/IN
KDO/NN
and/CC
IFN-β/JJ
activate/VBP
GAS/NN
promoters/NNS
,/,
either/CC
directly/RB
or/CC
indirectly/RB
./.
====================
KDO/NN
abrogated/VBD
the/DT
anti-inflammatory/JJ
properties/NNS
of/IN
8-Br/JJ
====================
Supplementary/JJ
Table/JJ
5/CD
shows/VBZ
the/DT
genes/NNS
regulated/VBN
upon/IN
double-ligand/JJ
treatment/NN
with/IN
KDO/NN
and/CC
8-Br/NN
./.
====================
Importantly/RB
,/,
combined/JJ
KDO/NN
and/CC
8-Br/NN
application/NN
increased/VBD
the/DT
transcription/NN
of/IN
Tnf/JJ
but/CC
did/VBD
not/RB
affect/VB
Ccl4/NN
,/,
Map3k8/NN
,/,
or/CC
c-Myc/NN
(/(
Fig/NN
./.
====================
3A/NN
)/)
./.
====================
Since/IN
8-Br/JJ
downregulated/VBD
these/DT
genes/NNS
during/IN
the/DT
single-ligand/JJ
application/NN
studies/NNS
,/,
these/DT
results/NNS
suggested/VBD
that/IN
the/DT
KDO-induced/JJ
pathway/NN
attenuated/VBD
these/DT
8-Br-induced/JJ
changes/NNS
./.
====================
We/PRP
classified/VBD
the/DT
direct/JJ
targets/NNS
of/IN
CREB/NN
(/(
major/JJ
TF/NN
induced/VBD
by/IN
cAMP/NN
analogs/NNS
)/)
and/CC
NF-κB/NN
(/(
direct/JJ
target/NN
of/IN
KDO/NN
)/)
to/TO
see/VB
which/WDT
of/IN
the/DT
major/JJ
transcription/NN
factors/NNS
are/VBP
affected/VBN
(/(
Table/JJ
2/CD
)/)
./.
====================
For/IN
CREB/NN
,/,
we/PRP
searched/VBD
in/IN
the/DT
website/JJ
developed/VBD
by/IN
Marc/NN
Montminy/JJ
,/,
which/WDT
takes/VBZ
advantage/NN
of/IN
CHIP-on-chip/NN
data/NNS
(/(
http/NN
:/:
//natural.salk.edu/CREB/NN
)/)
./.
====================
For/IN
potent/JJ
NF-κB/NN
sites/NNS
,/,
we/PRP
looked/VBD
in/IN
the/DT
website/JJ
http/NN
:/:
//www.bu.edu/nf-kb/JJ
./.
====================
Surprisingly/RB
,/,
both/CC
of/IN
these/DT
transcription/NN
factors/NNS
are/VBP
not/RB
affected/VBN
by/IN
double/JJ
ligand/NN
treatment/NN
of/IN
KDO/NN
and/CC
8-Br/NN
,/,
reinsisting/VBG
that/DT
KDO/NN
directly/RB
inhibits/VBZ
8-Br-induced/JJ
changes/NNS
./.
====================
CREB/NN
can/MD
be/VB
induced/VBN
to/TO
a/DT
certain/JJ
extent/NN
through/IN
the/DT
ERK/NN
pathway/NN
by/IN
KDO/NN
;/:
however/RB
,/,
such/JJ
a/DT
claim/NN
remains/VBZ
to/TO
be/VB
proven/VBN
in/IN
the/DT
future/JJ
studies/NNS
./.
====================
This/DT
approach/NN
further/RBR
raises/VBZ
a/DT
question/NN
on/IN
by/IN
which/WDT
mechanism/NN
,/,
if/IN
not/RB
CREB/NN
and/CC
NF-κB/NN
,/,
KDO/NN
attenuates/NNS
8-Br/NN
induced/VBD
changes/NNS
,/,
which/WDT
also/RB
remains/VBZ
to/TO
be/VB
tested/VBN
./.
====================
One/CD
possible/JJ
explanation/NN
for/IN
this/DT
phenomenon/NN
is/VBZ
that/DT
KDO/NN
stimulation/NN
rapidly/RB
downregulated/VBD
the/DT
8-Br-induced/JJ
increase/VBP
in/IN
intracellular/JJ
cAMP/NN
through/IN
the/DT
action/NN
of/IN
phosphodiesterases/NNS
(/(
PDEs/NNS
)/)
that/WDT
transform/VBP
cAMP/NN
into/IN
inactive/JJ
AMP/NN
[/(
38/CD
]/)
./.
====================
In/IN
support/NN
of/IN
this/DT
idea/NN
,/,
LPS/NN
stimulation/NN
of/IN
mouse/NN
peripheral/JJ
leukocytes/NNS
induced/VBD
Pde4b/NN
mRNA/NN
accumulation/NN
and/CC
increased/VBD
PDE4/NN
activity/NN
[/(
39/CD
]/)
./.
====================
This/DT
increase/NN
in/IN
PDE4/NN
activity/NN
leads/VBZ
to/TO
a/DT
decrease/NN
in/IN
cAMP/NN
,/,
thus/RB
removing/VBG
the/DT
cAMP/NN
constraint/NN
and/CC
allowing/VBG
for/IN
full/JJ
induction/NN
of/IN
Tnf/JJ
mRNA/NN
./.
====================
PKA/NN
phosphorylation/NN
inhibits/VBZ
Raf1/NN
directly/RB
[/(
40/CD
,/,
41/CD
]/)
,/,
and/CC
this/DT
inhibition/NN
occurs/VBZ
downstream/RB
of/IN
Ras/NN
[/(
42/CD
,/,
43/CD
]/)
to/TO
inhibit/VB
Ras-dependent/JJ
signaling/NN
to/TO
ERK/NN
[/(
44/CD
]/)
./.
====================
Hence/RB
,/,
Raf/NN
can/MD
be/VB
the/DT
crosstalk/NN
point/NN
between/IN
the/DT
KDO/NN
and/CC
8-Br/NN
signal/NN
transduction/NN
pathways/NNS
./.
====================
KDO/NN
and/CC
IFN-β/JJ
suppressed/VBD
the/DT
effects/NNS
of/IN
8-Br/JJ
in/IN
triple-ligand/NN
studies/NNS
====================
Supplementary/JJ
Table/JJ
6/CD
shows/VBZ
the/DT
transcriptional/JJ
responses/NNS
in/IN
RAW/NN
264.7/CD
cells/NNS
upon/IN
triple-ligand/NN
stimulation/NN
./.
====================
We/PRP
observed/VBD
the/DT
following/VBG
effects/NNS
:/:
1/LS
)/)
upregulation/RB
of/IN
the/DT
primary/JJ
and/CC
secondary/JJ
KDO-/NNP
and/CC
IFN-β-responsive/JJ
genes/NNS
;/:
2/LS
)/)
production/NN
of/IN
various/JJ
inflammatory/JJ
cytokines/NNS
and/CC
their/PRP$
receptors/NNS
(/(
Il-1a/NNP
,/,
Il-1b/NNP
,/,
Il-6/RB
,/,
Il-20/NNP
,/,
Il-17rb/NNP
,/,
Il-15/NNP
,/,
Il-18/NNP
,/,
Il-13/NNP
,/,
Il-4ra/NNP
,/,
Il-10ra/NNP
,/,
and/CC
Tnf/NNP
)/)
and/CC
the/DT
anti-inflammatory/JJ
cytokine/NN
Il-10/NN
;/:
3/LS
)/)
induction/NN
of/IN
apoptosis-inducing/VBG
transcription/NN
factors/NNS
(/(
Fosl-1/NN
,/,
Atf3/NNP
,/,
Egr1/NNP
,/,
Egr2/NNP
,/,
Fos-b/NNP
,/,
Jun/NNP
dimerization/NN
protein/NN
[/(
Jdp/NNP
]/)
,/,
and/CC
Irf14/NNP
)/)
;/:
and/CC
4/CD
)/)
up-regulation/RB
of/IN
multiple/JJ
G-protein-coupled/JJ
receptors/NNS
,/,
like/IN
leukotriene/NN
B4/NN
receptor1/RB
(/(
Ltb4r1/NNP
)/)
,/,
complement/RB
component/NN
5a/RB
receptor/NN
1/LS
(/(
C5ar1/NNP
)/)
,/,
chemokine/NN
(/(
c-c/JJ
)/)
receptor/NN
1/LS
(/(
Ccr1/NNP
)/)
,/,
Gpr132/NNP
,/,
Gpr65/NNP
,/,
and/CC
calcitonin/JJ
receptor-like/JJ
(/(
Calcr1/NNP
)/)
./.
====================
In/IN
these/DT
triple-ligand/NN
studies/NNS
,/,
the/DT
transcription/NN
factors/NNS
exerting/VBG
the/DT
greatest/JJS
regulatory/JJ
control/NN
over/IN
gene/NN
expression/NN
were/VBD
NF-κB/JJ
,/,
Ap1/NN
,/,
Nfat/NN
,/,
Stat2/NN
,/,
and/CC
Stat3/NN
./.
====================
Our/PRP$
data/NNS
demonstrated/VBD
that/IN
concomitant/JJ
stimulation/NN
with/IN
all/DT
three/CD
ligands/NNS
induced/VBN
KDO/NN
and/CC
IFN-β/JJ
primary/JJ
and/CC
secondary/JJ
responsive/JJ
genes/NNS
,/,
but/CC
it/PRP
repressed/VBD
8-Br-induced/JJ
transcriptional/JJ
changes/NNS
./.
====================
Triple-ligand/CC
stimulation/NN
revealed/VBD
Il-6/NN
gene/NN
induction/NN
does/VBZ
not/RB
require/VB
de/FW
novo/FW
synthesis/NN
of/IN
NF-κBζ/JJ
====================
We/PRP
observed/VBD
an/DT
interesting/JJ
transcriptional/JJ
change/NN
in/IN
gene/NN
clusters/NNS
(/(
Fig/NN
./.
====================
6/CD
)/)
./.
====================
NF-κBζ/JJ
is/VBZ
weakly/RB
expressed/VBN
in/IN
cells/NNS
but/CC
induced/VBD
to/TO
a/DT
marked/JJ
extent/NN
upon/IN
LPS/NN
stimulation/NN
and/CC
regulates/VBZ
a/DT
set/NN
of/IN
gene/NN
expression/NN
,/,
including/VBG
Il-6/NN
[/(
45/CD
]/)
./.
====================
However/RB
,/,
a/DT
recent/JJ
study/NN
demonstrated/VBD
that/IN
Il-6/NN
promoter/NN
can/MD
also/RB
be/VB
activated/VBN
by/IN
unknown/JJ
molecules/NNS
acting/VBG
far/RB
from/IN
the/DT
transcriptional/JJ
active/JJ
site/NN
by/IN
cis-regulatory/JJ
molecules/NNS
[/(
46/CD
]/)
./.
====================
We/PRP
observed/VBD
the/DT
same/JJ
phenomenon/NN
when/WRB
we/PRP
stimulated/VBD
RAW/NN
264.7/CD
cells/NNS
with/IN
KDO/NN
./.
====================
NF-κBζ/JJ
was/VBD
upregulated/VBN
by/IN
KDO/NN
at/IN
60/CD
min/NN
,/,
and/CC
Il-6/NN
was/VBD
not/RB
induced/VBN
by/IN
KDO/NN
till/JJ
120/CD
min/NN
,/,
which/WDT
is/VBZ
in/IN
line/NN
with/IN
a/DT
previous/JJ
observation/NN
[/(
45/CD
]/)
./.
====================
This/DT
observation/NN
is/VBZ
very/RB
novel/JJ
to/TO
be/VB
explained/VBN
./.
====================
Triple-ligand/CC
studies/NNS
showed/VBD
upregulation/NN
of/IN
Il-6/NN
as/IN
early/JJ
as/IN
60/CD
min/NN
(/(
about/RB
6-fold/RB
)/)
./.
====================
This/DT
indicates/VBZ
that/IN
though/IN
KDO-induced/JJ
pathways/NNS
need/VBD
de/FW
novo/FW
synthesis/NN
of/IN
NF-κBζ/JJ
for/IN
Il-6/NN
production/NN
,/,
it/PRP
does/VBZ
not/RB
require/VB
de/FW
novo/FW
synthesis/NN
of/IN
NF-κBζ/JJ
for/IN
the/DT
induction/NN
of/IN
Il-6/NN
when/WRB
combined/VBN
with/IN
IFN-β/JJ
and/CC
8-Br/JJ
./.
====================
We/PRP
then/RB
looked/VBD
for/IN
the/DT
possible/JJ
ligand/NN
that/DT
could/MD
have/VB
mediated/VBN
this/DT
and/CC
found/VBD
that/IN
KDO/NN
and/CC
8-Br/NN
never/RB
produced/VBN
Il-6/NN
on/IN
single-ligand/JJ
stimulation/NN
./.
====================
In/IN
that/DT
case/NN
,/,
the/DT
only/RB
remaining/VBG
candidate/NN
is/VBZ
IFN-β/JJ
./.
====================
IFN-β/JJ
upregulated/VBN
Il-6/NN
in/IN
our/PRP$
experiment/NN
at/IN
120/CD
min/NN
(/(
TLR3/NN
can/MD
produce/VB
Il-6/NN
due/JJ
to/TO
the/DT
late/JJ
phase/NN
of/IN
NF-κB/NN
activation/NN
)/)
./.
====================
IFN-β/JJ
also/RB
increased/VBD
mRNAs/NNS
of/IN
Atf3/NN
,/,
Ccl4/NN
,/,
and/CC
Map3k8/NN
at/IN
120/CD
min/NN
./.
====================
It/PRP
is/VBZ
of/IN
interest/NN
to/TO
know/VB
what/WP
pathway/NN
regulates/VBZ
these/DT
genes/NNS
in/IN
future/JJ
studies/NNS
,/,
since/IN
most/JJS
of/IN
them/PRP
were/VBD
reported/VBN
to/TO
be/VB
regulated/VBN
by/IN
a/DT
MyD88-dependent/JJ
pathway/NN
during/IN
TLR/NN
signaling/NN
./.
====================
Either/DT
the/DT
presence/NN
of/IN
a/DT
putative/JJ
STAT1/NN
site/NN
is/VBZ
sufficient/JJ
to/TO
induce/VB
the/DT
MyD88-dependent/JJ
genes/NNS
or/CC
IFN-β/JJ
might/MD
have/VB
crosstalk/NN
with/IN
the/DT
MAPK/NN
pathway/NN
./.
====================
In/IN
RAW/NN
cells/NNS
and/CC
primary/JJ
macrophages/NNS
,/,
LPS-induced/JJ
signaling/NN
is/VBZ
mainly/RB
passed/VBN
through/IN
the/DT
activation/NN
of/IN
the/DT
NF-κB/IκB/NN
kinase/NN
(/(
IKK/NN
)/)
pathways/NNS
./.
====================
The/DT
p50/NN
and/CC
RelA/NN
complex/NN
mediates/VBZ
the/DT
majority/NN
of/IN
genes/NNS
induced/VBN
by/IN
LPS/NN
./.
====================
In/IN
our/PRP$
studies/NNS
,/,
many/JJ
induced/VBN
genes/NNS
appeared/VBD
to/TO
be/VB
activated/VBN
as/IN
a/DT
primary/JJ
consequence/NN
of/IN
initial/JJ
NF-κB/NN
activation/NN
./.
====================
Although/IN
the/DT
induction/NN
of/IN
the/DT
genes/NNS
was/VBD
through/IN
the/DT
NF-κB/NN
pathway/NN
,/,
few/JJ
genes/NNS
were/VBD
differentially/RB
expressed/VBN
when/WRB
we/PRP
combined/VBD
the/DT
ligands/NNS
./.
====================
We/PRP
have/VBP
restricted/JJ
our/PRP$
studies/NNS
to/TO
2/CD
h/NN
;/:
hence/RB
,/,
we/PRP
can/MD
not/RB
emphasize/VB
on/IN
the/DT
secondary/JJ
sequences/NNS
of/IN
NF-κB/NN
,/,
but/CC
we/PRP
observed/VBD
that/IN
most/JJS
of/IN
the/DT
induced/VBN
genes/NNS
have/VBP
putative/JJ
or/CC
known/VBN
AP-1/NN
or/CC
IRF-3/NN
sites/NNS
./.
====================
The/DT
gene/NN
expression/NN
in/IN
dual/JJ
treatment/NN
of/IN
IFN-β/JJ
and/CC
KDO/NN
was/VBD
specifically/RB
mediated/VBN
by/IN
STAT/NN
proteins/NNS
and/CC
NF-κB/NN
./.
====================
Also/RB
,/,
gene/NN
transcription/NN
during/IN
macrophage/NN
activation/NN
through/IN
TLR4/NN
and/CC
the/DT
elevation/NN
of/IN
IFN-β/JJ
simultaneously/RB
resulted/VBD
in/IN
alterations/NNS
in/IN
the/DT
chromatin/NN
structure/NN
of/IN
gene/NN
promoters/NNS
that/IN
further/RB
influenced/VBN
transcription/NN
initiation/NN
events/NNS
./.
====================
Combining/VBG
IFN-β/JJ
and/CC
KDO/NN
induced/VBD
the/DT
IFN-β/JJ
secondary/JJ
responsive/JJ
genes/NNS
Gbp1/NN
,/,
Gbp2/NNP
,/,
and/CC
Gbp5/NN
by/IN
more/RBR
than/IN
4-fold/JJ
,/,
but/CC
it/PRP
attenuated/VBD
several/JJ
KDO/NN
secondary/JJ
responsive/JJ
genes/NNS
,/,
including/VBG
Socs5/NN
,/,
Cish/NNP
,/,
Fosl/JJ
,/,
Rgs16/NN
,/,
Cxcr9/NN
,/,
Ifit3/NN
,/,
and/CC
Ctf1/NN
./.
====================
In/IN
contrast/NN
,/,
dual/JJ
KDO/NN
and/CC
IFN-β/JJ
treatment/NN
enhanced/VBD
the/DT
expression/NN
of/IN
several/JJ
transcription/NN
factors/NNS
after/IN
60/CD
and/CC
120/CD
min/NN
of/IN
stimulation/NN
,/,
most/JJS
notably/RB
Atf3/NN
./.
====================
Atf3/DT
is/VBZ
a/DT
stress-inducible/JJ
member/NN
of/IN
the/DT
Atf/Creb/NN
transcription/NN
factor/NN
family/NN
[/(
47/CD
]/)
,/,
and/CC
according/VBG
to/TO
a/DT
recent/JJ
systems/NNS
biological/JJ
approach/NN
,/,
Atf3/NN
negatively/RB
regulates/VBZ
TLR4-induced/JJ
Il-6/NN
and/CC
Il-12/NN
transcription/NN
[/(
48/CD
]/)
./.
====================
As/IN
evident/JJ
from/IN
our/PRP$
QRT-PCR/NN
results/NNS
,/,
IFN-β/JJ
never/RB
regulated/VBN
MyD88-independent/JJ
genes/NNS
except/IN
Il-10/NN
./.
====================
However/RB
,/,
IFN-β/JJ
treatment/NN
during/IN
TLR4/NN
signaling/NN
increased/VBD
Rantes/NNS
,/,
Il-10/NN
,/,
and/CC
Tnf/NN
levels/NNS
./.
====================
It/PRP
is/VBZ
interesting/JJ
to/TO
note/VB
that/IN
that/IN
there/EX
should/MD
be/VB
a/DT
competition/NN
for/IN
the/DT
common/JJ
signaling/NN
repressors/NNS
and/CC
activators/NNS
of/IN
the/DT
inflammatory/JJ
ligand/NN
TNF/NN
and/CC
anti-inflammatory/JJ
ligand/NN
Il-10/NN
at/IN
approximately/RB
4/CD
h/NN
of/IN
signaling/VBG
./.
====================
It/PRP
is/VBZ
also/RB
worthwhile/IN
to/TO
note/VB
that/IN
if/IN
TNF/NN
pathways/NNS
dominate/VBP
,/,
it/PRP
should/MD
lead/VB
to/TO
increased/VBN
Il-10-repressed/JJ
genes/NNS
and/CC
direct/JJ
the/DT
cells/NNS
into/IN
the/DT
apoptosis/NN
pathway/NN
./.
====================
In/IN
addition/NN
to/TO
this/DT
effect/NN
,/,
we/PRP
observed/VBD
upregulation/NN
but/CC
not/RB
enhanced/VBN
levels/NNS
of/IN
NF-κB/NN
p105/NN
,/,
implicating/VBG
this/DT
subunit/NN
in/IN
KDO/NN
and/CC
IFN-β/JJ
responses/NNS
not/RB
only/RB
through/IN
IκB-NF-κB/NN
interaction/NN
but/CC
also/RB
through/IN
transcriptional/JJ
regulation/NN
./.
====================
The/DT
elevated/JJ
KDO/NN
and/CC
IFN-β/JJ
primary/JJ
and/CC
secondary/JJ
responsive/JJ
genes/NNS
were/VBD
not/RB
unexpected/JJ
,/,
considering/VBG
that/DT
we/PRP
observed/VBD
higher/JJR
NF-κB/NN
signaling/NN
and/CC
endogenous/JJ
production/NN
of/IN
IFN-β/JJ
under/IN
double-ligand/JJ
stimulation/NN
./.
====================
This/DT
suggests/VBZ
that/IN
there/EX
exists/VBZ
some/DT
crosstalk/NN
and/CC
pathway/NN
modulation/NN
in/IN
a/DT
positive/JJ
way/NN
that/DT
increased/VBD
the/DT
levels/NNS
of/IN
gene/NN
expression/NN
./.
====================
Macrophages/NNS
,/,
when/WRB
infected/VBN
with/IN
pathogenic/JJ
Gram-negative/JJ
bacteria/NNS
,/,
lead/VBP
to/TO
the/DT
induction/NN
of/IN
about/RB
1,000/CD
genes/NNS
,/,
and/CC
almost/RB
all/DT
of/IN
these/DT
genes/NNS
were/VBD
reported/VBN
to/TO
be/VB
induced/VBN
only/RB
though/IN
the/DT
TLR4/NN
signaling/NN
cascade/NN
./.
====================
Excessive/JJ
production/NN
of/IN
cytokines/NNS
or/CC
inflammatory/JJ
agents/NNS
is/VBZ
always/RB
associated/VBN
with/IN
sepsis/NN
and/CC
shock/NN
./.
====================
The/DT
data/NNS
presented/VBN
in/IN
our/PRP$
microarray/NN
also/RB
show/VBP
that/IN
KDO/NN
and/CC
LPS/NN
induce/VBP
identical/JJ
gene/NN
expression/NN
profiles/NNS
./.
====================
This/DT
suggests/VBZ
that/IN
the/DT
contribution/NN
of/IN
other/JJ
family/NN
members/NNS
of/IN
TLR/NN
is/VBZ
minor/JJ
,/,
and/CC
TLR4/NN
on/IN
the/DT
whole/JJ
contributes/VBZ
to/TO
KDO-induced/JJ
gene/NN
expression/NN
changes/NNS
./.
====================
Further/RB
,/,
most/JJS
of/IN
these/DT
gene/NN
responses/NNS
were/VBD
mediated/VBN
by/IN
the/DT
MyD88-dependent/JJ
pathway/NN
,/,
which/WDT
is/VBZ
essential/JJ
for/IN
the/DT
optimal/JJ
induction/NN
of/IN
many/JJ
well-established/JJ
cytokines/NNS
,/,
like/IN
Il-1/NN
,/,
TNF/NN
,/,
Il-10/NN
,/,
Il-12/NN
,/,
and/CC
Il-6/NN
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
in/IN
our/PRP$
microarray/NN
studies/NNS
,/,
we/PRP
observed/VBD
that/IN
Tnf/JJ
and/CC
other/JJ
inflammatory/JJ
genes/NNS
were/VBD
downregulated/VBN
by/IN
8-Br/JJ
,/,
whereas/IN
upregulated/VBN
Il-10/NN
levels/NNS
./.
====================
However/RB
,/,
in/IN
double-ligand/JJ
treatment/NN
,/,
KDO/NN
abrogated/VBD
all/DT
the/DT
gene/NN
responses/NNS
of/IN
8-Br/JJ
./.
====================
cAMP-dependent/JJ
and/CC
-independent/JJ
signaling/NN
mechanisms/NNS
may/MD
be/VB
involved/VBN
in/IN
mediating/VBG
the/DT
gene/NN
regulation/NN
during/IN
double-ligand/JJ
stimulation/NN
with/IN
KDO/NN
and/CC
8-Br/NN
./.
====================
Another/DT
observation/NN
was/VBD
the/DT
differential/JJ
regulation/NN
of/IN
mRNAs/NNS
of/IN
Il-1β/NN
,/,
Il-1α/NN
,/,
and/CC
Tnf/NN
by/IN
KDO/NN
and/CC
8-Br/NN
./.
====================
Ccl3/NN
,/,
Ccl4/NN
,/,
Il-1β/NNP
,/,
Tnf-α/NNP
,/,
and/CC
Gadd45β/FW
are/VBP
the/DT
genes/NNS
whose/WP$
promoters/NNS
have/VBP
been/VBN
proven/VBN
to/TO
be/VB
regulated/VBN
by/IN
RelA/NN
[/(
49/CD
]/)
./.
====================
In/IN
our/PRP$
studies/NNS
,/,
all/DT
these/DT
genes/NNS
were/VBD
found/VBN
to/TO
be/VB
upregulated/VBN
at/IN
60/CD
min/NN
of/IN
KDO/NN
treatment/NN
,/,
which/WDT
is/VBZ
consistent/JJ
with/IN
a/DT
previous/JJ
report/NN
[/(
50/CD
]/)
./.
====================
However/RB
,/,
8-Br/NN
increased/VBD
Il-1β/NN
levels/NNS
,/,
but/CC
it/PRP
did/VBD
not/RB
increase/VB
Tnf/IN
levels/NNS
./.
====================
Both/DT
genes/NNS
are/VBP
regulated/VBN
through/IN
the/DT
MyD88-dependent/JJ
signaling/NN
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
there/EX
was/VBD
no/DT
change/NN
in/IN
Il-1α/NN
levels/NNS
./.
====================
In/IN
double-ligand/JJ
stimulation/NN
,/,
all/DT
these/DT
changes/NNS
were/VBD
reversed/VBN
./.
====================
We/PRP
tried/VBD
to/TO
find/VB
answers/NNS
through/IN
the/DT
promoter/NN
and/CC
transcription/NN
factor/NN
search/VBP
analysis/NN
./.
====================
Transcription/NN
factors/NNS
evolved/VBD
to/TO
regulate/VB
the/DT
gene/NN
expression/NN
,/,
and/CC
they/PRP
have/VBP
the/DT
ability/NN
to/TO
modify/VB
the/DT
expression/NN
of/IN
a/DT
given/VBN
gene/NN
./.
====================
Since/IN
Tnf/JJ
is/VBZ
downregulated/VBN
by/IN
8-Br/JJ
at/IN
60/CD
min/NN
itself/PRP
,/,
it/PRP
should/MD
be/VB
happening/VBG
either/CC
at/IN
the/DT
promoter/NN
level/NN
or/CC
at/IN
the/DT
primary/JJ
pathway/NN
level/NN
./.
====================
Although/IN
Tnf/JJ
has/VBZ
AP1/NN
binding/NN
sites/NNS
,/,
it/PRP
is/VBZ
not/RB
sufficient/JJ
to/TO
induce/VB
Tnf/NN
mRNA/NN
,/,
whereas/IN
NF-κB/NN
is/VBZ
necessary/JJ
for/IN
its/PRP$
upregulation/NN
./.
====================
8-Br/DT
should/MD
have/VBP
affected/VBN
the/DT
translocation/NN
of/IN
p65/p50/NN
subunit/NN
to/TO
the/DT
nucleus/NN
./.
====================
Il-1β/NN
is/VBZ
highly/RB
expressed/VBN
in/IN
activated/VBN
macrophages/NNS
and/CC
monocytes/NNS
,/,
and/CC
LPS/NN
is/VBZ
a/DT
well-established/JJ
stimulus/NN
for/IN
its/PRP$
induction/NN
./.
====================
Il-1β/NN
has/VBZ
one/CD
or/CC
more/RBR
CREB/NN
binding/NN
sites/NNS
in/IN
the/DT
promoter/NN
./.
====================
Since/IN
8-Br/JJ
activates/VBZ
CREB/NN
,/,
the/DT
presence/NN
of/IN
one/CD
or/CC
more/RBR
CREB/NN
sites/NNS
seems/VBZ
to/TO
be/VB
sufficient/JJ
for/IN
its/PRP$
induction/NN
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
Il-1α/NN
mRNA/NN
level/NN
was/VBD
not/RB
changed/VBN
./.
====================
With/IN
the/DT
information/NN
available/JJ
on/IN
its/PRP$
regulation/NN
,/,
it/PRP
seems/VBZ
that/DT
the/DT
AP1/NN
site/NN
is/VBZ
necessary/JJ
for/IN
its/PRP$
induction/NN
./.
====================
8-Br-induced/JJ
pathways/NNS
may/MD
have/VB
either/CC
directly/RB
or/CC
indirectly/RB
affected/VBN
AP1/NN
translocation/NN
to/TO
the/DT
nucleus/NN
./.
====================
In/IN
this/DT
context/NN
,/,
to/TO
support/VB
our/PRP$
notion/NN
,/,
we/PRP
observed/VBD
the/DT
downregulation/NN
of/IN
some/DT
AP1/NN
genes/NNS
./.
====================
8-Br-induced/JJ
pathways/NNS
modulated/VBN
the/DT
MAPK/NN
pathway/NN
,/,
which/WDT
must/MD
have/VBP
happened/VBN
as/IN
a/DT
dual/JJ
channel/NN
./.
====================
First/RB
,/,
8-Br/NN
may/MD
have/VB
inhibited/VBN
the/DT
pathway/NN
upstream/JJ
of/IN
AP1/NN
./.
====================
Second/RB
,/,
it/PRP
should/MD
have/VBP
inhibited/VBN
the/DT
translocation/NN
of/IN
the/DT
specific/JJ
subunits/NNS
of/IN
AP1/NN
into/IN
the/DT
nucleus/NN
./.
====================
Gene/NN
regulation/NN
studies/NNS
of/IN
8-Br/JJ
suggest/VBP
the/DT
following/VBG
mechanism/NN
of/IN
the/DT
pathway/NN
activation/repression/NN
:/:
1/CD
)/)
8-Br/RB
affected/VBN
NF-κB/NN
activity/NN
directly/RB
;/:
2/CD
)/)
8-Br-induced/JJ
CREB/NN
is/VBZ
sufficient/JJ
to/TO
induce/VB
Il-1β/NN
expression/NN
;/:
and/CC
3/CD
)/)
8-Br/RB
affected/VBN
the/DT
different/JJ
subunits/NNS
of/IN
AP1/NN
specifically/RB
,/,
and/CC
at/IN
the/DT
same/JJ
time/NN
,/,
it/PRP
inhibited/VBD
the/DT
pathway/NN
of/IN
MAPK/NN
upstream/RB
of/IN
AP1/NN
./.
====================
PDEs/NNS
are/VBP
enzymes/NNS
that/WDT
catalyze/VBP
the/DT
hydrolysis/NN
of/IN
cAMP/NN
and/CC
cGMP/NN
,/,
inactivating/VBG
these/DT
second/JJ
messengers/NNS
[/(
51/CD
]/)
./.
====================
PDE/NN
consists/VBZ
of/IN
11/CD
families/NNS
,/,
and/CC
amongst/IN
them/PRP
four/CD
,/,
including/VBG
PDE4/NN
,/,
PDE7/NN
,/,
and/CC
PDE8/NN
,/,
are/VBP
cAMP-specific/JJ
[/(
52/CD
]/)
./.
====================
PDE4/NN
isoforms/NNS
are/VBP
major/JJ
inactivators/NNS
of/IN
cAMP/NN
signaling/NN
[/(
53/CD
]/)
./.
====================
In/IN
our/PRP$
studies/NNS
,/,
stimulation/NN
of/IN
TLR/NN
caused/VBD
a/DT
major/JJ
upregulation/NN
of/IN
PDE4B/NN
but/CC
not/RB
the/DT
paralogs/NNS
PDE4A/NN
or/CC
PDE4D/NN
./.
====================
Ablation/NN
of/IN
PDE4B/NN
impacted/JJ
LPS/NN
signaling/NN
,/,
and/CC
TNF-α/NN
mRNA/NN
and/CC
protein/NN
were/VBD
decreased/VBN
by/IN
>/JJR
50/CD
%/NN
in/IN
PDE4B-/-/JJ
but/CC
not/RB
in/IN
PDE4A-/-/JJ
or/CC
PDE4D-/-/JJ
macrophages/NNS
[/(
54/CD
]/)
./.
====================
This/DT
indicates/VBZ
the/DT
powerful/JJ
role/NN
of/IN
PDE4B/NN
in/IN
macrophages/NNS
,/,
by/IN
inhibiting/VBG
cAMP/NN
and/CC
its/PRP$
critical/JJ
role/NN
in/IN
LPS/NN
signaling/NN
./.
====================
Another/DT
possible/JJ
explanation/NN
for/IN
this/DT
pathway/NN
modulation/NN
is/VBZ
the/DT
interaction/NN
between/IN
NF-κB/NN
and/CC
PKA/NN
./.
====================
Since/IN
the/DT
catalytic/JJ
subunit/NN
of/IN
PKA/NN
works/VBZ
as/IN
a/DT
complex/JJ
with/IN
NF-κB/IκB/NN
in/IN
the/DT
inactive/JJ
state/NN
[/(
55/CD
]/)
,/,
stimuli/NNS
that/IN
degrade/VBP
IκB/NN
also/RB
activate/VBP
the/DT
associated/VBN
PKA/NN
catalytic/JJ
subunit/NN
,/,
which/WDT
promotes/VBZ
the/DT
phosphorylation/NN
of/IN
p65/NN
at/IN
Ser/NN
276/CD
and/CC
increases/VBZ
the/DT
transcriptional/JJ
activity/NN
of/IN
NF-κB/JJ
./.
====================
Two/CD
GPCR/NN
ligands/NNS
,/,
isoproterenol/NN
and/CC
prostaglandin/NN
E2/NN
,/,
induce/VBP
cAMP/NN
through/IN
the/DT
activation/NN
of/IN
Gαs/NN
and/CC
adenylate/NN
cyclase/NN
./.
====================
cAMP/NN
production/NN
inhibits/VBZ
pro-inflammatory/JJ
mediators/NNS
,/,
including/VBG
TNF/NN
and/CC
nitric/JJ
oxide/NN
in/IN
RAW/NN
264.7/CD
cells/NNS
[/(
56/CD
,/,
57/CD
]/)
./.
====================
Apart/RB
from/IN
this/DT
,/,
multiple/JJ
signaling/NN
pathways/NNS
or/CC
mechanisms/NNS
are/VBP
likely/JJ
to/TO
be/VB
involved/VBN
in/IN
mediating/VBG
gene/NN
responses/NNS
to/TO
KDO/NN
and/CC
8-Br/NN
./.
====================
In/IN
some/DT
cases/NNS
,/,
an/DT
increase/NN
in/IN
cAMP/NN
level/NN
by/IN
pituitary/JJ
adenylate/NN
cyclase/NN
blocks/VBZ
IκB/NN
degradation/NN
,/,
p65/Rel/NN
translocation/NN
,/,
and/or/CC
the/DT
rearrangement/NN
of/IN
CREB/Jun/CREB-binding/JJ
protein/NN
(/(
CBP/NN
)/)
complexes/NNS
[/(
58/CD
]/)
./.
====================
In/IN
other/JJ
cases/NNS
,/,
an/DT
increase/NN
in/IN
cAMP/NN
is/VBZ
directly/RB
proportional/JJ
to/TO
the/DT
decrease/NN
in/IN
MAPK/ERK/NN
kinase/NN
(/(
MEK/NN
)/)
kinase/NN
pathways/NNS
[/(
59/CD
]/)
,/,
and/CC
transactivating/VBG
properties/NNS
of/IN
PKA/NN
are/VBP
reported/VBN
to/TO
be/VB
involved/VBN
in/IN
NF-κB/NN
activation/NN
[/(
60/CD
]/)
./.
====================
After/IN
60/CD
min/NN
,/,
triple-ligand/CC
treatment/NN
upregulated/VBD
many/JJ
transcription/NN
factors/NNS
,/,
such/JJ
as/IN
Nr4a2/NN
,/,
Crem/NN
,/,
Atf3/NN
,/,
Irf8/NNP
,/,
Nfkbp100/NN
,/,
Egr2/NN
,/,
Egr1/NN
,/,
Cish/NNP
,/,
Stat3/NN
,/,
Stat2/NN
,/,
Irf1/NNP
,/,
and/CC
FosB/NN
./.
====================
After/IN
120/CD
min/NN
of/IN
stimulation/NN
,/,
we/PRP
observed/VBD
upregulated/VBN
zinc/NN
finger/NN
and/CC
BTB/NN
domain-containing/JJ
32/CD
(/(
Zbtb32/NN
)/)
,/,
Fosl1/NN
,/,
RelB/NN
,/,
Irf7/NNP
,/,
LPS-induced/JJ
TNF-α/NN
factor/NN
(/(
Litaf/NN
)/)
,/,
and/CC
Jundm2/NN
./.
====================
Although/IN
the/DT
regulatory/JJ
mechanisms/NNS
of/IN
these/DT
genes/NNS
are/VBP
complex/NN
,/,
they/PRP
all/DT
culminate/VBP
in/IN
the/DT
production/NN
of/IN
various/JJ
pro-inflammatory/JJ
cytokines/NNS
./.
====================
NIH3T3/NN
cells/NNS
,/,
when/WRB
stimulated/VBN
with/IN
the/DT
cAMP/NN
analog/NN
forskolin/NN
,/,
activate/VBP
p38/NN
by/IN
PKA/NN
,/,
which/WDT
in/IN
turn/NN
phosphorylates/VBZ
CREB/NN
through/IN
RSK2/NN
./.
====================
However/RB
,/,
this/DT
process/NN
is/VBZ
delayed/VBN
in/IN
comparison/NN
with/IN
the/DT
direct/JJ
phosphorylation/NN
of/IN
CREB/NN
by/IN
PKA/NN
[/(
61/CD
]/)
./.
====================
This/DT
study/NN
shows/VBZ
that/IN
there/EX
exist/VBP
crosstalk/NN
mechanisms/NNS
between/IN
PKA/NN
and/CC
p38/NN
,/,
thus/RB
allowing/VBG
the/DT
cells/NNS
to/TO
prolong/VB
the/DT
incoming/VBG
signal/NN
./.
====================
Both/DT
LPS/NN
and/CC
the/DT
cAMP/NN
analog/NN
8-Br/NN
activate/VBP
p38/NN
,/,
like/IN
forskolin/NN
,/,
forming/VBG
the/DT
crosstalk/NN
points/NNS
between/IN
GPCR/NN
and/CC
Toll-like/JJ
receptor/NN
./.
====================
This/DT
mechanism/NN
would/MD
have/VBP
partly/RB
contributed/VBD
to/TO
the/DT
observed/VBN
dominant/JJ
gene/NN
signature/NN
of/IN
KDO/NN
in/IN
triple-ligand/NN
studies/NNS
./.
====================
We/PRP
also/RB
noted/VBN
that/IN
there/EX
exist/VBP
substantial/JJ
differences/NNS
in/IN
the/DT
gene/NN
expression/NN
profiles/NNS
of/IN
RAW/NN
264.7/CD
cells/NNS
and/CC
primary/JJ
macrophages/NNS
./.
====================
For/IN
example/NN
,/,
TNF/NN
alpha/NN
is/VBZ
produced/VBN
highly/RB
in/IN
RAW/NN
264.7/CD
cells/NNS
than/IN
in/IN
macrophages/NNS
,/,
and/CC
there/EX
are/VBP
quantitative/JJ
and/CC
temporal/JJ
differences/NNS
between/IN
these/DT
cells/NNS
./.
====================
The/DT
KDO-induced/JJ
gene/NN
signature/NN
dominated/JJ
over/IN
IFN-β/JJ
and/CC
the/DT
8-Br-induced/JJ
gene/NN
signature/NN
./.
====================
In/IN
addition/NN
,/,
we/PRP
also/RB
explained/VBN
the/DT
genes/NNS
that/WDT
have/VBP
the/DT
ability/NN
to/TO
act/VB
as/IN
positive/JJ
(/(
Tnf/NNP
,/,
Il-1/NN
)/)
[/(
62/CD
,/,
63/CD
]/)
and/CC
negative/JJ
feedback/NN
(/(
Il-1ra/NN
)/)
[/(
64/CD
]/)
regulators/NNS
of/IN
KDO/NN
signaling/NN
./.
====================
Excessive/JJ
activation/NN
of/IN
cytokines/NNS
is/VBZ
associated/VBN
with/IN
septic/JJ
shock/NN
and/CC
clinical/JJ
consequences/NNS
of/IN
inflammatory/JJ
disorders/NNS
./.
====================
It/PRP
is/VBZ
also/RB
of/IN
interest/NN
that/IN
many/JJ
genes/NNS
induced/VBN
by/IN
8-Br/NN
have/VBP
the/DT
potential/JJ
to/TO
act/VB
as/IN
anti-inflammatory/JJ
actions/NNS
./.
====================
Thus/RB
,/,
our/PRP$
studies/NNS
prove/VBP
that/IN
elevating/VBG
intracellular/JJ
cAMP/NN
levels/NNS
during/IN
the/DT
times/NNS
of/IN
immunological/JJ
stress/NN
might/MD
ameliorate/VB
the/DT
shock-induced/JJ
mortality/NN
./.
====================
Taken/VBN
together/RB
,/,
our/PRP$
study/NN
identified/VBD
several/JJ
target/NN
genes/NNS
that/WDT
are/VBP
activated/repressed/VBN
by/IN
KDO/NN
,/,
IFN-β/JJ
,/,
and/or/CC
8-Br/NN
in/IN
RAW/NN
264.7/CD
cells/NNS
./.
====================
Based/VBN
on/IN
these/DT
data/NNS
,/,
we/PRP
also/RB
proposed/VBN
regulatory/JJ
signaling/NN
networks/NNS
that/DT
could/MD
be/VB
responsible/JJ
for/IN
the/DT
crosstalk/NN
between/IN
Toll-like/JJ
receptors/NNS
and/CC
non-Toll-like/JJ
receptors/NNS
,/,
such/JJ
as/IN
GPCRs/NNS
./.
====================
These/DT
findings/NNS
not/RB
only/RB
highlight/VBP
the/DT
decisive/JJ
regulation/NN
of/IN
various/JJ
genes/NNS
by/IN
three/CD
important/JJ
ligands/NNS
but/CC
also/RB
add/VBP
depth/NN
to/TO
our/PRP$
broad/JJ
understanding/VBG
of/IN
biological/JJ
signaling/NN
connections/NNS
between/IN
complex/NN
systems/NNS
of/IN
functionally/RB
interacting/VBG
macromolecules/NNS
./.
====================
Gene/NN
responses/NNS
in/IN
macrophages/NNS
to/TO
LPS/NN
vary/VBP
between/IN
different/JJ
methylation/NN
patterns/NNS
[/(
65/CD
]/)
,/,
sub-clones/NNS
of/IN
RAW/NN
264.7/CD
cells/NNS
[/(
66/CD
]/)
,/,
chromatin/NN
structure/NN
of/IN
gene/NN
promoters/NNS
,/,
and/CC
chromatin/NN
remodeling/NN
events/NNS
[/(
67/CD
]/)
./.
====================
To/TO
define/VB
the/DT
action/NN
of/IN
a/DT
given/VBN
ligand/NN
,/,
it/PRP
is/VBZ
necessary/JJ
to/TO
rule/JJ
out/RP
these/DT
options/NNS
and/CC
particularly/RB
emphasize/VBP
on/IN
the/DT
true/JJ
effects/NNS
of/IN
a/DT
ligand/NN
./.
====================
Though/IN
our/PRP$
studies/NNS
form/VBP
the/DT
basis/NN
for/IN
the/DT
novel/JJ
regulatory/JJ
pathways/NNS
of/IN
gene/NN
induction/NN
during/IN
macrophage/NN
action/NN
,/,
future/JJ
studies/NNS
are/VBP
warranted/VBN
to/TO
construct/VB
a/DT
signaling/NN
map/VBP
./.
====================
The/DT
transcriptional/JJ
signature/NN
of/IN
RAW/NN
264.7/CD
cells/NNS
after/IN
stimulation/NN
with/IN
2-keto-3-deoxyoctonate/JJ
(/(
KDO/NN
)/)
,/,
interferon-β/JJ
(/(
IFN-β/JJ
)/)
,/,
and/CC
8-bromoadenosine-3',5'-cyclic/JJ
monophosphate/NN
(/(
8-Br/CD
)/)
./.
====================
(/(
A/DT
)/)
The/DT
bars/NNS
in/IN
the/DT
diagram/NN
represent/VBP
the/DT
numbers/NNS
of/IN
differentially/RB
expressed/VBN
genes/NNS
at/IN
60/CD
min/NN
and/CC
120/CD
min/NN
of/IN
stimulation/NN
,/,
as/IN
assessed/VBN
with/IN
Limma/NN
./.
====================
(/(
B/NN
)/)
Hierarchical/JJ
clustering/NN
of/IN
responses/NNS
to/TO
60/CD
min/NN
and/CC
120/CD
min/NN
of/IN
stimulation/NN
was/VBD
conducted/VBN
using/VBG
K-means/JJ
clustering/NN
and/CC
visualized/VBD
by/IN
MeV/NN
software/JJ
./.
====================
The/DT
cluster/NN
shown/VBN
represents/VBZ
those/DT
macrophage/NN
genes/NNS
that/WDT
were/VBD
significantly/RB
regulated/VBN
by/IN
KDO/NN
,/,
IFN-β/JJ
,/,
or/CC
8-Br/JJ
treatment/NN
./.
====================
Red/VBN
squares/VBZ
represent/VBP
genes/NNS
that/WDT
were/VBD
upregulated/VBN
,/,
black/JJ
squares/VBZ
indicate/VBP
no/DT
change/NN
,/,
and/CC
green/VBN
squares/VBZ
indicate/VBP
downregulated/VBD
genes/NNS
./.
====================
Top/RB
functions/NNS
and/CC
tumor/NN
necrosis/NN
factor/NN
(/(
TNF/NN
)/)
networks/NNS
./.
====================
(/(
A/NN
)/)
The/DT
top/NN
functions/NNS
for/IN
all/DT
treatments/NNS
./.
====================
As/IN
noted/VBN
,/,
various/JJ
treatments/NNS
had/VBD
various/JJ
effects/NNS
on/IN
their/PRP$
respective/JJ
pathways/NNS
and/CC
functions/NNS
,/,
with/IN
2-keto-3-deoxyoctonate/JJ
(/(
KDO/NN
)/)
the/DT
most/JJS
active/JJ
ligand/NN
,/,
followed/VBN
by/IN
interferon-β/JJ
(/(
IFN-β/JJ
)/)
and/CC
8-bromoadenosine-3',5'-cyclic/JJ
monophosphate/NN
(/(
8-Br/CD
)/)
./.
====================
(/(
B/NN
)/)
TNF/NN
networks/NNS
./.
====================
Ingenuity/NN
pathway/NN
analysis/NN
(/(
IPA/NN
)/)
pictures/VBZ
show/VBP
the/DT
down-/NN
and/CC
upregulation/NN
of/IN
the/DT
ligand-induced/JJ
gene/NN
expression/NN
changes/NNS
./.
====================
Dual-ligand/CC
analysis/NN
of/IN
2-keto-3-deoxyoctonate/JJ
(/(
KDO/NN
)/)
and/CC
8-bromoadenosine-3',5'-cyclic/JJ
monophosphate/NN
(/(
8-Br/CD
)/)
./.
====================
(/(
A/NN
)/)
Clustering/NN
of/IN
KDO/NN
and/CC
8-Br-induced/JJ
gene/NN
expression/NN
changes/NNS
./.
====================
(/(
B/NN
)/)
MotifMogul/NNP
picture/NN
showing/VBG
the/DT
promoter/NN
analysis/NN
of/IN
Tnf/JJ
,/,
c-Myc/NN
,/,
and/CC
Gadd45α/FW
./.
====================
Quantitative/JJ
real-time/VBP
PCR/NN
validation/NN
of/IN
genes/NNS
regulated/VBN
by/IN
2-keto-3-deoxyoctonate/JJ
(/(
KDO/NN
)/)
,/,
interferon-β/JJ
(/(
IFN-β/JJ
)/)
,/,
or/CC
KDO/NN
+/JJ
IFN-β/JJ
./.
====================
KDO/NN
enhanced/VBD
the/DT
expression/NN
of/IN
RANTES/NN
and/CC
interleukin/NN
10/CD
(/(
IL-10/NN
)/)
together/RB
with/IN
IFN-β/JJ
./.
====================
G-CSF/NN
,/,
granulocyte-colony/JJ
stimulating/NN
factor/NN
;/:
TNF/NN
,/,
tumor/NN
necrosis/NN
factor/NN
./.
====================
Dual-ligand/CC
analysis/NN
of/IN
2-keto-3-deoxyoctonate/JJ
(/(
KDO/NN
)/)
and/CC
interferon-β/JJ
(/(
IFN-β/JJ
)/)
./.
====================
(/(
A/NN
)/)
Cytokine/NN
analysis/NN
of/IN
non-additive/JJ
genes/NNS
in/IN
KDO/NN
and/CC
IFN-β/JJ
stimulation/NN
./.
====================
(/(
B/NN
)/)
Stat1/NN
phosphoprotein/NN
analysis/NN
upon/IN
KDO/NN
and/CC
IFN-β/JJ
stimulation/NN
./.
====================
(/(
C/NN
)/)
KDO/NN
and/CC
IFN-β/JJ
signaling/NN
mechanisms/NNS
./.
====================
GAS/NN
,/,
gamma/NN
activated/VBN
sequence/NN
;/:
G-CSF/NN
,/,
granulocyte-colony/JJ
stimulating/NN
factor/NN
;/:
IL/NN
,/,
interleukin/NN
;/:
IRF3/NN
,/,
interferon-regulatory/JJ
factor/NN
3/CD
;/:
ISRE/NN
,/,
interferon-stimulated/JJ
response/NN
element/NN
;/:
JAK/TYK/NN
,/,
Janus/NN
kinase/tyrosine/NN
kinase/NN
;/:
STAT/NN
,/,
signal/NN
transducer/NN
and/CC
activator/NN
of/IN
transcription/NN
;/:
TLR4/NN
,/,
Toll-like/JJ
receptor/NN
4/CD
;/:
TNF/NN
,/,
tumor/NN
necrosis/NN
factor/NN
./.
====================
Regulation/NN
of/IN
NF-κBζ/JJ
and/CC
interleukin/NN
6/CD
(/(
Il-6/NN
)/)
by/IN
all/DT
ligands/NNS
./.
====================
(/(
A/DT
)/)
NF-κBζ/JJ
,/,
which/WDT
is/VBZ
highlighted/VBN
in/IN
black/JJ
arrow/NN
,/,
was/VBD
regulated/VBN
by/IN
2-keto-3-deoxyoctonate/JJ
(/(
KDO/NN
)/)
as/IN
well/RB
as/IN
by/IN
triple-ligand/NN
stimulation/NN
in/IN
RAW/NN
264.7/CD
cells/NNS
./.
====================
(/(
B/NN
)/)
Il-6/NN
was/VBD
regulated/VBN
by/IN
interferon-β/JJ
(/(
IFN-β/JJ
)/)
at/IN
120/CD
min/NN
,/,
but/CC
triple/JJ
ligands/NNS
upregulated/VBN
Il-6/NN
robustly/RB
as/IN
early/JJ
as/IN
60/CD
min/NN
itself/PRP
./.
====================
8-Br/CD
,/,
8-bromoadenosine-3',5'-cyclic/JJ
monophosphate/NN
./.
====================
Number/NN
of/IN
features/NNS
showing/VBG
non-additive/JJ
responses/NNS
in/IN
double-ligand/JJ
studies/NNS
with/IN
KDO/NN
,/,
IFN-β/JJ
,/,
and/CC
8-Br/NN
====================
The/DT
potent/JJ
CREB/NN
and/CC
NF-κB/NN
sites/NNS
were/VBD
searched/VBN
,/,
and/CC
their/PRP$
presence/NN
or/CC
absence/NN
is/VBZ
listed/VBN
====================
